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ABSTRACT OF THE DISSERTATION 
Prenatal Undernutrition, Metyrapone, and the Cerebrovasculature 
by 
Lara Durrant 
Doctor of Philosophy, Graduate Program in Physiology 
Loma Linda University, June 2017 
Dr. William J. Pearce, Chairperson 
 
The link between intrauterine environmental conditions and adult cardiovascular 
system is well established. Independent of lifestyle factors such as poor diet and exercise 
habits, individuals who have been exposed to stressful conditions in utero show an 
increased risk of health problems such as hypertension, stroke, and type II diabetes. In 
support of the Fetal Origin of Adult Disease hypothesis, many labs have reported 
permanent anatomical and physiological changes associated with fetal stress and nutrient 
deficiency, with a focus on organ systems such as the kidney and heart. One key idea 
proposed by many of these studies is the glucocorticoid hypothesis, which suggests that 
fetal stress develops at least in part by fetal overexposure to stress hormones, like 
glucocorticoids, during gestation. However, few studies have looked at the glucocorticoid 
hypothesis in the context of blood vessels of the brain. In our first study (cohort 1), 
pregnant female Sprague-Dawley rats were exposed to 50% maternal undernutrition 
during the last ten days of gestation. One subgroup was also administered Metyrapone, a 
corticosterone synthesis inhibitor, during gestation. After delivery, the pups were allowed 
to grow to maturity at 8-months of age, at which time their middle cerebral arteries were 
harvested and examined using a combination of vessel bath myography and confocal 
microscopy. In our second study (cohort 2), pregnant female Sprague-Dawley rats were 
xii 
exposed to Metyrapone (±). On postnatal day 9-10, the rats then underwent Hypoxia-
Ischemia (±) (unilateral carotid ligation combined with 1.5 hours 8% hypoxia after 24 
hours). The goal of both studies was to determine whether glucocorticoids would increase 
ischemic vulnerability, an important marker of vascular health. Our results demonstrated 
that food restriction as well as perturbations to early glucocorticoid exposure are critical 
to the development of the cerebrovasculature, and that pharmacological glucocorticoid 
inhibition during gestation can alter the vulnerability to mild hypoxic-ischemic injury. 
Future studies are currently in progress to determine the ultimate effects of food 
restriction on the cerebrovasculature during the neonatal period. 
 
1 
CHAPTER ONE 
INTRODUCTION 
 
Fetal Programming and Adult Origins of Adult Disease 
The Fetal Origins of Adult Disease hypothesis was first proposed and developed by Dr. 
David Barker, an epidemiologist, based on historical data collected from the Dutch Famine of 
1944-45 (4). During World War II, the food supply to parts of the western Netherlands was 
severely limited, triggering the start of what would become the Hunger Winter in September of 
1944. Many adults began to receive less than 1000 kcal per day. In May 1945, after many months 
of hardship and strict food rationing, the food supply lines were restored and the famine ended. 
However, its legacy would extend far into the future. By studying the birth records, it was found 
that infants whose mothers had been exposed to the famine were smaller at birth and showed an 
increased risk of developing type II diabetes, obesity, stroke and hypertension as adults (2), and 
that these effects persisted through several generations (14). These findings have since been 
duplicated in multiple laboratory settings and have been interpreted to support the general theory 
of “fetal programming”.  
The main principle behind fetal programming is that a fetus retains a certain level of 
phenotypic plasticity as it develops, and is able to actively sense, adapt, and react to in utero 
stressors such as hypoxia, poor nutrition, or maternal infections (51). Subsequently, the fetus is 
better able to survive, even under suboptimal environmental conditions. However, since these 
adaptations often take the form of tissue remodeling via epigenetic mechanisms, they may result 
in permanent anatomical changes (33), particularly if they occur during a critical developmental 
window. Further, it is believed that these changes can predispose the fetus to later disease. Hence, 
what may be adaptive for an infant’s short term survival may not be optimal for their long-term 
health. In regard to specific mechanisms, glucocorticoid programming is considered to be one of 
the main effectors that play a role in fetal programming. Environmentally-induced epigenetic 
2 
changes, such as those induced by food restriction or maternal nicotine use, are also thought to be 
key players in fetal programming. Some examples of epigenetic mechanisms include altered 
promoter methylation, histone acetylation, and miRNA synthesis and activity (9). 
 
Nutritional Programming 
A growing fetus needs a steady source of nutrients to support its development. When 
nutrient flow is interrupted or compromised in any way, the fetus must adapt. Many efforts have 
been made to explain how these adaptations might occur. A key challenge to the study of 
maternal food restriction (MFR) is the wide variety of models that are found in the literature (32, 
52). There are models that selectively examine the effects of micronutrient (vitamins, trace 
nutrients, etc.) vs. macronutrient (protein, fat, carbohydrate) deprivation. Protein vs caloric 
restriction models have also been extensively studied. Generally speaking, programming effects, 
like food restriction, can be thought of through a “pharmacodynamics” lens such that the 
characteristics of the insult— dose, degree of exposure, individual characteristics of the 
developing fetus, etc.- are all important. Despite the variety of different models, however, the 
resulting phenotype is quite consistent, occurring independently of other lifestyle factors such as a 
Western or high fat diet. Typically, the MFR phenotype contributes to an altered pattern of fetal 
and placental growth (2), resulting in low birth weight offspring that later develop high blood 
pressure as adults (39). Because of the consistent effects of MFR on blood pressure, considerable 
research has focused on the kidney and the renin angiotensin aldosterone system (RAAS), and 
food restriction has been attributed to impaired nephrogenesis and kidney growth (34). Other 
organ systems, and in particular the brain, have remained understudied. One explanation for this 
might be the popularity of the brain sparing theory which proposes that a growing infant can 
compensate for decreased nutrients by increasing blood flow to critical organs such as the brain 
and heart (3, 11, 15), with the assumption that the brain would be protected. Supporting this 
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assertion are the observations that brain size relative to body size tends to be preserved even in 
very small infants.  Hemodynamic changes also occur in the vasculature that support brain 
sparing, such as altered contractility levels in the carotid artery in response to maternal food 
restriction (5). What has been called into question is not that it occurs, but rather what function it 
serves and whether it truly protects the brain (46, 58). In addition to brain sparing effects, 
vascular effects mediated by food restriction have also been reported, and MFR-induced changes 
in vascular structure have been noted in the aorta, the femoral artery, and the mesenteric artery 
(21, 29, 53).  
 
Stress Hormones and the HPA Axis 
The HPA axis is a major endocrine feedback system responsible for the long-term stress 
response that helps to coordinate the actions between three organs, the hypothalamus, the 
pituitary gland, and the adrenal glands. Briefly, the hypothalamus produces corticotrophin 
releasing hormone (CRH), stimulating the anterior pituitary to produce adrenocorticotropic 
hormone (ACTH), which in turn stimulates the adrenal cortex to produce glucocorticoid 
hormones (cortisol in humans, and corticosterone in rats). Rats also secrete small amounts of 
cortisol (17). Cortisol and corticosterone both have negative feedback effects on CRH and ACTH 
production, thus limiting their own production. The HPA axis plays an important role in 
maintaining homeostasis.  
Glucocorticoid hormones are essential for life, rise and fall in a circadian manner, and 
play a key role in cardiovascular function, the immune system, and metabolism (40). Cortisol has 
wide-reaching effects within the body. Once produced, glucocorticoids (GCs) may enter the 
circulation where they typically bind to corticosterone-binding globulin (CBG). Because GCs are 
fat-soluble hormones, they are able to pass through cell membranes and bind to intracellular 
glucocorticoid receptors (GR). The bound version of GR then interacts with glucocorticoid 
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response elements (GRE) as a ligand bound transcription factor in the cell’s nucleus in order to 
regulate gene transcription. Only a small number of GREs are actually bound by the GR at any 
one point in time, and the specific GREs that the GR binds to are often tissue-specific and may 
rely on chromatin availability. This is known as the classical pathway and, like many fat-soluble 
hormones, exhibits a slower response time as new protein takes time to be translated. There are 
also non-classical effects of GCs on cells, some of which may occur more quickly. They are 
thought to proceed through the activity of various kinases such as MAPK and AKT. There are 
also a number of GR splice variants, further complicating our understanding of the literature. 
Glucocorticoids can potentially have an effect on every tissue and the GR can be found in nearly 
every tissue including vascular smooth muscle cells (VSMCs). Glucocorticoids also bind to 
mineralocorticoid receptor (MR).  Because of their wide reaching effects, there is evidence that 
glucocorticoids can contribute to vascular changes, though they may not be the only player, and 
glucocorticoid-independent mechanisms may also be important. Glucocorticoids may potentiate 
the response to catecholamines leading to an increased response to norepinephrine within 
VSMCs, as well as regulate calcium homeostasis (57). 
 
Glucocorticoids and Pregnancy 
The placenta is a specialized organ that forms only during pregnancy that begins to 
develop upon implantation of the blastocyst into the uterine endometrium. The placenta forms the 
natural barrier between mother and baby. Its core purpose is multi-purposed. The placenta 
prevents maternal and fetal blood from mixing, regulates the exchange of oxygen and nutrition, it 
allows for temperature homeostasis, and controls waste removal for the fetus. It also performs a 
number of protective functions including hormone regulation. Glucocorticoids play a critical role 
during pregnancy. Cells of the placenta are a major source of CRH production during pregnancy, 
which helps to start the signal cascade for parturition (30). Other functions include the actions of 
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11-ß hyrdroxy steroid dehydrogenase isozyme 2 (BHSD2) and its ability to convert active cortisol 
to its inactive form (44). A major obstacle to the study of maternal and fetal endocrinology is that 
the fetal HPA axis, the maternal HPA axis, and hormone regulation by the placenta can all 
potentially influence each other. This becomes especially important when speaking about specific 
pathophysiological conditions during pregnancy, such as fetal stress. A hallmark feature of an 
intrauterine growth restricted fetus is the presence of a larger than normal placenta, which can be 
viewed as an adaptive response to the low-nutrient conditions with the larger placenta, i.e. 
increased surface area, attempting to compensate for the low substrate availability. Conceptually, 
the placenta can be viewed as the main filter through which the fetus evaluates its environment, 
such that any disease or nutrient-deficient state that interrupts nutrient or hormone signaling of 
the placenta could potentially cause a reaction in the fetus.  
 
Glucocorticoid Hypothesis of Food Restriction 
The precise mechanisms by which maternal food restriction exerts its deleterious 
physiological effects remain unknown. However, glucocorticoid effects via alterations of the 
hypothalamic pituitary adrenal (HPA) axis have been proposed as a major contributor (37). 
Known as the “glucocorticoid hypothesis,” the idea is that maternal stress leads to fetal stress by 
allowing the fetus to become exposed to high levels of maternal glucocorticoids. In a normal 
pregnancy, glucocorticoid levels can become quite high. Typically, the fetus is protected from 
these high levels by the placenta. The main barrier is the enzyme 11 ß-HSD2, which is thought to 
protect the fetus by converting cortisol to its inactive form cortisone (in the rat, corticosterone is 
converted to 11-dehydrocorticosterone) (36, 44). However, it has been shown that this 
mechanism may become compromised in food restricted offspring, leading to excess 
glucocorticoid exposure. Maternal administration of antenatal glucocorticoids produce a similar 
phenotype compared with MFR models, and also result in adverse health outcomes in the long-
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term (6). Hypertension is one of the most frequently reported characteristics of glucocorticoid 
programming, illustrating the point that the vasculature appears to be especially targeted by these 
developmental changes. Despite extensive evidence, however, the glucocorticoid hypothesis is 
controversial, and some labs have reported that programming changes can occur in the absence of 
elevated glucocorticoid levels  (12, 24). Hence, there remains the possibility that glucocorticoids 
may play an important, but nonessential role, in the programming effects of food restriction. 
 
Metyrapone 
Metryapone, or metopirone, (see Figure 1 for its chemical structure) is a 
reversible cytochrome P-450 11 ß-HSD hydoxylase inhibitor that acts on the 
corticosterone synthesis pathway by inhibiting the synthesis of steroid 11-ß-
monooxygenase. Metyrapone is used clinically to treat Cushing’s syndrome and to 
diagnose adrenal insufficiency. Metyrapone has been used as an effective way to dampen 
glucocorticoid levels during pregnancy so as to study the long-term programming effects 
and mechanisms of excess glucocorticoid (GC) exposure in utero. (38, 42). Several 
studies have examined the effects of MET-only treatment during pregnancy.  Female rats 
whose mothers received Metyrapone were shown to have slightly longer estrous cycles 
and delayed puberty when compared to controls (48).  However, neither embryonic 
weight nor allantoic size differed when Metyrapone was administered in a pig model 
from days 14 through 19 (54).  Metyrapone, when administered during pregnancy is well 
tolerated (19) and results in otherwise healthy offspring with minor differences which 
could be expected from its effects on glucocorticoid synthesis. With only minimal side 
effects, Metyrapone has been shown to be highly effective at lowering plasma 
glucocorticoid levels during pregnancy (26). This combination of properties have 
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contributed to its popularity as an important tool in understanding the role of GCs during 
pregnancy. 
 
Figure 1. Chemical Structure of Metyrapone.  
 
Myogenic Tone 
Although the cardiovascular system has been proposed as a major target of food 
restriction-related programming, the cerebrovasculature has received little attention in the 
literature. Brain tissue is very metabolically active and cannot survive long without a steady 
blood flow of nutrients. Effective maintenance of perfusion by blood vessels is critical to brain 
function. so it is not surprising that cerebral blood vessels have developed a number of features 
that allow them fulfill this purpose. Myogenic tone is one such mechanism that appears to be 
particularly important in cerebral arteries. Myogenic tone (also known as the Bayliss effect) is an 
intrinsic property of blood vessels, usually arteries or arterioles, that helps to ensure that tissue 
perfusion remains constant despite pressure changes (13). One of the main functions of myogenic 
tone, thus, is to regulate blood flow, thereby preventing ischemia due to low blood pressure 
(hypoperfusion) or tissue damage due to high blood pressure (hyperperfusion) (47). Myogenic 
tone is especially important in the vasculature of the brain. While vascular resistance may be 
modified by sympathetic and endothelial effects, the myogenic response is independently 
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controlled by vascular smooth muscle cells. Myogenic tone can be thought of as an indicator of 
overall vascular health which may be altered during various pathological conditions, including 
stroke and hypertension (10). Because its functionality can be compromised by certain stressful 
conditions, understanding its underlying mechanisms is critical.  
The vasculature of young animals is functionally and structurally different than that of 
the adult, and certain age-related changes need to be taken into account. First, the dynamic range 
of immature or developing blood vessels is much smaller. Outside of that range, blood flow is 
only passively (not actively) controlled by myogenic mechanisms (8). There is also evidence that 
a smaller number of contractile cells in neonatal arteries are doing proportionally more of the 
work compared to adult arteries (7). Given these findings, the myogenic responses during these 
key developmental periods may be more sensitive to injury. It isn’t difficult to imagine how an 
infant whose brain is subjected to sudden spikes or drops in blood pressure due to an impaired 
myogenic response may be more vulnerable to ischemic injury. This innate vulnerability may be 
one reason as to why stroke rates are higher during the perinatal period, occurring at about 1 in 
2300 to 1 in 5000 live births (43). By comparison, adults, especially among elderly populations, 
have a higher rate of stroke. Even so, the potential long-term impact of neonatal stroke should not 
be underestimated. Hence, it is critical to understand these age-related differences and how they 
may specifically effect the developing brain.  
 
Vascular Smooth Muscle Cells 
Vascular smooth muscle cells (VSMCs) are critical to understanding the myogenic 
response (13). Simply put, VSMCs provide the key structures by which a contraction can occur. 
Smooth muscle cell contraction proceeds largely through Ca++ dependent mechanisms and has 
been extensively studied (49). SMC contraction consists of three main phases: 1) activation of 
receptors by hormones or neurotransmitters, which activate a number of GTP binding proteins, 2) 
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changes in Ca++ levels either by influx from the extracellular space, release from the sarcoplasmic 
reticulum, sequestration within the sarcoplasmic reticulum, or extrusion of calcium into the 
extracellular space, and 3) changes in myosin light chain phosphorylation (25).  Typically, it is 
accepted that phosphorylation of myosin light chain (MLC) by myosin light chain kinase 
(MLCK) or de-phosphorylation by myosin light chain phosphatase (MLCP) can selectively 
control the level of contraction or dilation in SMCs which provides calcium sensitization. A 
number of other factors can further modulate and fine-tune the overall Ca++ sensitivity of a vessel, 
including Rho Kinase (ROCK) (50). The amount of intracellular calcium ([Ca++]i) and the Ca++ 
sensitivity together control force generation, and the levels of [Ca++]i and Ca++ can be selectively 
modified to meet the requirements of the vessel. Another key point is that some types of smooth 
muscle cells, particularly immature SMCs, do not participate in contraction and force generation. 
Indeed, it has been found that SMCs can exist in a variety of non-contractile phenotypes 
including proliferative and synthetic stages. There is a dynamic equilibrium between the many 
types of VSMCs and VSMCs retain the ability to differentiate or dedifferentiate based on 
changing conditions (41). They also have the ability to change their local environment through 
the production of extracellular matrix components; certain VSMCs may have more fibroblast-like 
properties. While some cells from each stage will likely be found in any given tissue, a number of 
factors such as age and environment appear to play a role in the overall distribution of different 
cell types. For example, it has been reported that SMCs may change phenotypes in response to 
tissue damage or injury (49). This may potentially explain the findings that both maternal food 
restriction and glucocorticoids appear to influence extracellular matrix remodeling (27, 28), 
perhaps by altering the phenotype of VSMCs. Thus, a change in SMC phenotype, no matter the 
initial cause, could in turn alter the myogenic response and, subsequently, may affect an artery’s 
ability to auto-regulate. 
10 
Neurovascular Regulation and the Cerebrovascular Anatomy 
As alluded to previously, the brain is a highly metabolically active tissue that is 
extremely energy sensitive. Even a short period without oxygen, as little as five minutes, can lead 
to neuronal death. Fortunately, the vascular anatomy provides an excellent source of redundancy 
in the form of the Circle of Willis. Even if one side is occluded, the collateral perfusion can often 
compensate. However, there are some regions of the brain such as the cerebral cortex, 
hippocampus, and sub-ventricular zone that may be more sensitive than others, perhaps due to 
less collateral backup flow. One important concept is that of functional hyperemia and the idea of 
neurovascular coupling. At the most basic, it is the careful matching of neural activity with the 
proper degree of vascular perfusion. Examples include when a person exercises or when they are 
asleep. Highly metabolically active areas receive more perfusion in this model. This is 
accomplished partly by way of cerebral autoregulation. Again, while the cerebral vasculature can 
be partly modulated by signals from neurons, the endothelium, and various other hormones, a 
main contributor is myogenic tone. In the brain, there exists a normal auto regulatory range where 
the flow can be dynamically controlled. Problems begin to occur when that auto regulatory range 
is shifted too far to the right or left. High blood pressure is one such condition under which the 
range of flow is no longer properly regulated. Hence, if blood pressure fluctuates too much, the 
protective mechanisms no longer work, exposing the tissues to hypo- or hyperperfusion. These 
mechanisms can also become damaged during and after stroke, such as with vessel vasospasm. 
Factors such as hypertension, diabetes, and acute ischemia may all act as vascular risk factors, 
altering the structure and function of a vascular bed and impairing the endogenous protective 
mechanisms, thereby worsening the outcome should an ischemic event occur. A healthy vascular 
bed, on the other hand, may provide some degree of resistance to disease or injury.  
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Perinatal Hypoxic-ischemic Encephalopathy 
Perinatal hypoxic-ischemic encephalopathy (HIE) is a major cause of morbidity that 
results in lifelong disability (1, 31), with neonatal stroke averaging about $50,000 per case in the 
first five years of life for medical care alone (16). Neonates who suffer perinatal stroke can have 
long term developmental consequences such as delayed puberty, missed developmental 
milestones, and intellectual disabilities. Causes of HIE include asphyxia related to birth trauma, 
maternal infections, and blood clotting disorders including sickle cell anemia have been 
implicated. Even worse, milder neonatal stroke is often difficult to diagnose with babies typically 
presenting with generalized symptoms such as lethargy, which could be attributed to a number of 
conditions. 
In an adult stroke patient with evidence of a cerebral thrombosis, or blood clot in the 
brain, tissue plasminogen activator (tPA) is the treatment of choice if a diagnosis can be made 
within 4 hours post-stroke (after which point tPA administration is contraindicated due to the risk 
of cerebral hemorrhage). Endardectomy, or the surgical removal of occluding material from an 
artery, is also an option if the presence of a lesion can be confirmed via imaging and is readily 
accessible. However, surgical intervention is highly controversial in infants and children, and 
would only apply to cases where there is a confirmed blood clot, which may not always be the 
case. In recent years, there has been evidence that therapeutic hypothermia may be beneficial for 
perinatal stroke (20). However, as with tPA, there is a narrow therapeutic window, limiting its 
potential usefulness, and the treatment is dependent on early detection (55). Instead, most 
treatments for neonatal stroke center around supportive care and the careful monitoring of vitals 
such as blood pressure and electrolyte balance. More treatment options and detection methods 
need to be developed.  
Research in a laboratory setting has centered around the use of experimental animal 
models. The most commonly used method for studying neonatal stroke is the Rice Vannucci 
model in which a rat pup, typically at age P7, undergoes surgery to have one of their carotid 
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arteries ligated (45). They are then allowed to recover for an hour or two before then being 
exposed to 8% oxygen. The length of oxygen deprivation typically spans about 1-2 hours and is 
the time at which the damage occurs. It is the result of both ischemia (the lack of blood flow) 
combined with hypoxia (low oxygen).  The Rice-Vannucci model is associated with a relatively 
low mortality rate and is characterized by white matter damage, typically in areas of high 
myelinogenesis. Animal models, in combination with clinical models, have provided important 
information about what happens during an ischemic event. One well-supported theory of HIE 
injury is the glutamate toxicity theory in which dying neurons release toxic levels of certain 
neurotransmitters (i.e. glutamate) and Ca++, resulting in more neuronal death (18). While much is 
known about the signal cascade following an ischemic insult, the targeting of specific neuronal 
death pathways has not led to any significant advances in therapy options.  
One potential therapeutic approach for hypoxia-ischemia that remains relatively 
unexplored is to target aspects of the cerebrovasculature (such as calcium sensitivity) or the risk 
factors that lead to impaired vessel health. It has been reported that vascular autoregulation is 
impaired in premature infants, especially in those infants that are already at risk for ischemia (22, 
56). The presence of immature vasculature that is unable to properly auto-regulate may increase 
the likelihood of an ischemic insult. Targeting specific mechanisms of the vasculature might be 
helpful after a stroke has already occurred. Another strategy might be to pursue preventative care 
in the case of high-risk pregnancies. For example, it may be possible to leverage pre-ischemic 
conditioning mechanisms in the hopes of promoting brain ischemic tolerance. Brain ischemic 
tolerance is the activation of endogenous neuroprotective mechanisms in response to an otherwise 
noxious stimulus. Stated simply, ischemic tolerance is a therapeutic exposure to a mild stress may 
leave a target tissue resistant to a later, more severe, stress (35). In the heart, this has been shown 
to take place, whereby ischemic resistance is conferred during a critical window of time, 
protecting the tissue from further damage.  Unfortunately, the effect typically wears off within a 
specific interval of time. With respect to the brain, it may be possible for a chronic low-grade 
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insult such as food restriction or mild hypoxia to induce a more permanent programming effect, 
thereby conferring some lasting amount of ischemic tolerance to an acute stressor. In either case, 
endogenous protective mechanisms would likely play a major role in determining the ultimate 
vulnerability of an individual to an ischemic stroke. The ideal scenario, of course, would be to 
develop a solution, pharmacological or otherwise, that might influence these pathways without 
compromising the health of the mother or fetus.  
 
Clinical Significance 
This dissertation sought to answer a number of questions including 1) how does food 
restriction alter early cerebrovascular development, 2) how does nutritional programming alter an 
infant’s ischemic vulnerability and cerebral autoregulation, and 3) how and in what ways do 
glucocorticoids mediate these processes. With food insecurity on the rise in certain population 
sectors (23), it is critical to determine the role that nutritional programming may play in long term 
health outcomes. With the number of premature infants also on the rise due to advances in 
neonatal care, it is likely that some of these infants will display signs of intrauterine growth 
restriction (IUGR) and may be administered glucocorticoids in order to promote fetal lung 
surfactant production in preparation for birth which may in itself contribute to programming (6). 
As these infants are likely to be prime candidates for later adult health problems, our 
understanding of early life programming must be expanded. A better understanding of the relative 
contribution of each component (nutrition, age, severity of stroke, etc.) will be key in the search 
for effective treatment options. 
From a basic science perspective, the research for this dissertation was highly innovative 
and offered an exciting opportunity to study contractility and smooth muscle cell phenotype 
changes in postnatal cerebral arteries in response to ischemic stroke and maternal undernutrition. 
Very little is currently known about the cerebrovasculature of young MFR animals and, to our 
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knowledge, this work, once completed, will be the first to investigate these food restricted pup 
cerebral arteries in such detail. Even compared with adult arteries, pup arteries are extremely 
small, fragile, and difficult to handle. However, with our carefully developed dissection 
techniques and expertise in vessel-bath myography, we have been in a unique position to study 
both the contractility and functional behavior of these arteries. By using advanced imaging 
techniques, we have gained insights into the state of the vasculature structure and gained a new 
perspective into the differentiation states of the vascular SMCs.  Importantly, this research has 
and will continue to build a strong foundation for future MFR studies. Together, this work will 
contribute greatly to our knowledge of how food restriction may permanently alter the developing 
cerebrovasculature. 
 
Purpose and Central Hypothesis 
The following studies were based on the core hypothesis that fetal programming, 
when induced by exposure to maternal food restriction, causes altered glucocorticoid 
responses, that lead to permanent changes in cerebrovasculature structure and function 
(see Figure 2). A corollary hypothesis was that endogenous protective mechanisms of the 
cerebrovasculature have been compromised due to altered glucocorticoid handling, 
leading to an increased susceptibility to ischemic stroke.  
 
 
Figure 2. Proposed Mechanism of MFR and Ischemic Vulnerability 
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Chapter Two, entitled “Maternal food restriction modulates cerebrovascular 
structure and contractility in adult rat offspring: effects of Metyrapone”, focused 
primarily on the long-term effects of food restriction on the cerebrovasculature in adults. 
In that study, we found that structure-function relationships of the middle cerebral 
arteries were permanently altered by 10 days of exposure to a 50% caloric restriction 
during the final 10 days of gestation. It was also found that certain components related to 
vascular structure, such as compliance, were influenced glucocorticoid signaling while 
other components such as K+-induced contractility were largely unaffected.  
Chapter Three, entitled “The impact of prenatal glucocorticoid inhibition on 
cerebrovascular structure and function in a model of mild hypoxia-ischemia”, was a 
collection of control experiments designed to determine whether the changes to the 
cerebrovasculature seen at 10-months of age due to food restriction and Metyrapone-
dosing (as discussed in Chapter Two) were also seen at in postnatal life. A secondary 
purpose was to determine what component of these changes were glucocorticoid-
dependent and which were glucocorticoid-independent, as well as the degree to which 
factors should as obesity may have played a role in vascular changes. These experiments 
did not involve food restriction and instead served to determine an appropriate baseline. 
These studies focused primarily on development with the added intent of determining the 
functional consequences of gestational glucocorticoid withdrawal on the postnatal 
vascular responses and responses to ischemic injury. Together, these experiments have 
paved the way for research that will be expanded on in Chapter Four.  
Chapter Four, entitled “Validation of a Model of Mild Ischemia”, primarily 
focused on experimental data that was currently in progress. A main aim of the work in 
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Chapter Four was to validate and develop a new milder and more clinically relevant 
ischemic injury model, complete with advanced imaging techniques including MRI. In 
this chapter, experimental data focused on the key features of the ischemic injury through 
histological analysis, MRI data, and behavior. The discussion also provided some 
speculation as to the question of how gestational Metyrapone might influence our 
Ischemia model.  
 Chapter Five included some closing remarks and the conclusion. This chapter 
sought to provide a perspective and framework future experiments. Altogether, this 
dissertation should provide a solid stepping point towards a survey of the current status of 
the effects of food restriction on the cererbrovasculature during early and adult life. 
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Abstract 
Although the effects of prenatal under-nutrition on adult cardiovascular health 
have been well studied, its effects on the cerebrovascular structure and function remain 
unknown.  We used a pair-fed rat model of 50% caloric restriction from day 11 of 
gestation to term, with ad libitum feeding after birth.  We validated that maternal food 
restriction (MFR) stress is mediated by glucocorticoids by administering Metyrapone 
(MET), a corticosterone synthesis inhibitor, to MFR mothers at day 11 of gestation.  At 
age 8-months, Control, MFR, and MFR+MET offspring were sacrificed and middle 
cerebral artery (MCA) segments were studied using vessel-bath myography and confocal 
microscopy. Colocalization of smooth muscle α-actin (SMαA) with non-muscle (NM) 
and SM2 myosin heavy chain (MHC) was used to assess smooth muscle phenotype.  Our 
results indicate that artery stiffness was increased, pressure-evoked myogenic reactivity 
was depressed, and myofilament Ca++ sensitivity was decreased in MFR compared to 
control offspring.  MCA from MFR offspring exhibited a significantly greater 
SMαA/NM colocalization, suggesting that the SMCs had been altered toward a non-
contractile phenotype.  MET significantly reversed the effects of MFR on stiffness but 
not myogenic reactivity, lowered SMαA/NM colocalization, and increased SMαA/SM2 
colocalization.  Together, our data suggest that MFR alters cerebrovascular contractility 
via both glucocorticoid-dependent and glucocorticoid-independent mechanisms. 
 
Introduction 
Based on his studies of the Dutch Famine in 1944, David Barker first proposed 
that in utero nutritional stress enhances the risk for adult-onset cardiovascular disease (7). 
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Equally important, the adult offspring of food-restricted mothers also exhibit increased 
risk for Type II diabetes, hypertension, and obesity (47). Given the increasing incidence 
of these diseases in many industrialized societies (51), it is possible that at least some of 
these cases are secondary to maternal undernutrition. In support of this possibility is the 
rising incidence of food insecurity in many population sectors, including some in 
industrialized societies (31). Given the relevance of these mechanisms, there have been 
many recent studies of “fetal origins of adult disease”. 
In the search for mechanisms mediating fetal programming secondary to maternal 
food restriction, an early hypothesis was that these effects were mediated by increases in 
maternal glucocorticoids (40, 43). Additional evidence further suggested that maternal 
food restriction modified expression of glucocorticoid receptors in cerebral tissues of 
their offspring (4, 44). Despite strong evidence for involvement of glucocorticoids in fetal 
responses to maternal food restriction, however, other studies have suggested parallel 
involvement of glucocorticoid-independent mechanisms (14), including changes in 
endothelial function (59), VEGF function (36), angiotensin II levels (50), vitamin D 
availability (2, 52), oxidative stress (62), and vascular miRNA (35).This diversity of 
evidence strongly suggests that fetal responses to maternal food restriction involve 
multiple interacting mechanisms that combine to produce the vascular phenotype typical 
of offspring from food-restricted mothers.  
Interpretation of the literature relevant to maternal food restriction is complicated 
by the broad variety of models and tissues used in these studies, many of which exhibit 
markedly different responses. In the kidney, maternal food restriction leads to reductions 
in kidney size, decreased nephron number, abnormalities in the renin-angiotensin system, 
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and decreased angiogenesis (36, 40, 69). Maternal food restriction also results in smaller 
heart sizes at birth, cardiomegaly in adult offspring, and coronary artery remodeling with 
fibrosis (9, 33). In the aorta, maternal food restriction can alter aortic structure leading to 
increased wall thickness and stiffness (36, 38). In contrast, maternal food restriction 
generally “spares” the fetal brain from major effects in the short term (17), but in the 
long-term can significantly alter brain structure (18) and function, leading to significant 
behavioral abnormalities (57). Aside from these general changes in the brain, the specific 
effects of maternal food restriction on cerebrovascular development and structure remain 
largely unstudied. 
To facilitate studies of the effects of maternal food restriction on the developing 
fetal cerebral circulation, we have developed a rat model involving 50% caloric 
restriction during the last 10 days of gestation with normal postnatal feeding(16). This 
model produces a milder nutritional insult than that obtained with food restriction 
throughout gestation and early postnatal life, thus increasing the fraction of pups 
surviving through adulthood (29). Because this model reduces only total caloric intake, it 
is also less severe than protein restriction models (5), but still produces the adult-onset 
hypertension and obesity characteristic of maternal undernutrition (37). With this model 
we have found that maternal food restriction can reduce VEGF expression and 
angiogenesis, can increase matrix metalloproteinase expression, and can alter multiple 
microRNA species that influence vascular development and function (35-37). 
In light of published evidence that Maternal Food Restriction (MFR) alters systemic 
vascular characteristics in adult offspring (7), the present study explores the hypothesis 
that MFR also influences vascular structure and function in the cerebral circulation of 
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adult offspring. In particular, the experimental approach examined the functional 
consequences of MFR for vascular stiffness and compliance in middle cerebral arteries 
from 8-month old rats whose dams underwent 50% caloric restriction during the final 10 
days of gestation. Separate experiments also examined changes in cerebral artery 
myogenic reactivity and smooth muscle phenotype attributable to MFR. To test the 
corollary hypothesis that the vascular effects of MFR arise from altered glucocorticoid 
signaling, we compared the effects of MFR in offspring from dams treated with or 
without Metyrapone, an inhibitor of 11-β hydroxylase that lowers circulating levels of 
corticosterone. Together, these experiments offered a unique perspective of the adult-
onset cerebrovascular consequences of MFR. 
 
Materials and Methods 
General Preparation 
All experimental procedures were approved by the Institutional Animal Use and 
Care Committees at both the Harbor-UCLA Medical Center and Loma Linda University.  
First- time-pregnant Sprague-Dawley rats (Charles River Laboratories, Inc., Hollister, 
CA) were housed at constant temperature and humidity with a 12h:12h light-dark cycle.  
At day 10 of gestation, rats were provided either an ad libitum diet of standard laboratory 
chow (Lab Diet 5001, Brentwood, MO: protein 23%, fat 4.5%, metabolizable energy 
3030 kcal/kg) or a diet of the same chow restricted to 50% of the intake measured by 
weight in paired, ad libitum fed rats. The respective diets were given from day 10 of 
pregnancy to term (21 days). Metyrapone (Sigma, M2696 at 0.5 mg/ml) was dissolved in 
drinking water and given from day 11 of gestation to term.   The dose of Metyrapone was 
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based on previous studies showing effective blockade of maternal corticosterone 
synthesis (61).  In light of multiple published reports that Metyrapone administration 
during gestation had no significant effects on birth weight or blood pressure in offspring 
of either rats (10, 41, 48) or pigs (39), a separate experimental group of control fed dams 
given Metyrapone was not included in the present study. 
Water consumption was monitored and did not differ from controls in dams 
receiving Metyrapone in their drinking water.  Maternal body weights and food intake 
were recorded daily.  At postnatal day 1, all offspring from food restricted and control rat 
dams were cross-fostered to rat dams fed ad libitum, and litter size was culled to 4 male 
and 4 female per dam.  Offspring were weaned at three weeks of age to ad libitum 
standardized laboratory chow.   After weaning, the animals were then raised to 8 months 
of age.  At this age, the animals were then transferred to Loma Linda University. 
The overall study design included three groups of Sprague-Dawley rats: 1) 8-
month old adults from control-fed mothers; 2) 8-month old adults from food-restricted 
mothers; and 3) 8-month adults from food-restricted mothers treated with Metyrapone.  
Following birth, all animals were housed under a 12h:12h light-dark cycle with food and 
water ad libitum.  At the time of study, rats were anaesthetized with 100% CO2 (1 
minute) and then decapitated.  The brains were rapidly removed and placed in ice cold 
physiological salt solution (PSS) containing (in mM): 130 NaCl, 10.0 HEPES, 6.0 
glucose, 4.0 KCl, 4.0 NaHCO3, 1.8 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, and 0.025 EDTA, 
at pH 7.4.  The main branch middle cerebral artery (MCA) was taken beginning at its 
origin adjacent to the Circle of Willis, cleaned of all connective tissue, and cut into 
lengths of 3-5 mm that were mounted on glass cannulas in an organ chamber positioned 
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on the stage of an inverted microscope (Living Systems, Burlington, VT).  The proximal 
cannula was connected to a pressure transducer and a windkessel reservoir of PSS, whose 
pressure was controlled by a pressure servo-control system used to precisely set and 
change the transmural pressures of the arteries. The distal cannula was connected to a 
Luer-lock valve that was opened to gently flush the lumen during the initial equilibration.  
After subsequent equilibration, the outflow valve was closed and all measurements were 
conducted under no-flow conditions.  Arterial diameters were recorded with the SoftEdge 
Acquisition Subsystem (Ion-Optix, Milton, MA). All methods used in this study have 
been previously described in detail (12, 13). 
 
Measurement of Smooth Muscle Calcium Concentration 
Once cannulated and equilibrated at 21 ̊C, the artery segments were loaded with 
fura-2 AM (Molecular Probes, Eugene, OR) for 20 minutes at a concentration of 1 µM as 
previously described (12, 13).  After loading, the arteries were washed with PSS and the 
bath temperature was increased to 37 ºC.  Photons emitted at 510 nm were detected at a 
sampling rate of 3 Hz using an IonOptix photomultiplier system that automatically 
corrected for background fluorescence.  Kd values obtained from separate in vitro 
calibrations were used to convert the experimental fluorescent intensity ratios (R) to 
[Ca2+]i over the physiological range by iterative fit to the Grynkiewicz equation: [Ca2+]i 
= Kd[(R-Rmin)/(Rmax- R)]Sf  (24). Our calculations using this equation employed the 
following averaged values: Sf (20.5), Rmin (0.3), Rmax (6.3), and Kd (251 nM). 
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Experimental Protocols 
All arteries were first exposed to PSS containing 120 mM K+ for 1 to 2 minutes 
at 60 mmHg to verify contractility, and all arteries were denuded of endothelium by 
perfusing 1 mm of air through the lumen of the vessel. When contractile responses had 
stabilized, the 120 mM K+ was replaced with normal PSS and the arteries were re-
equilibrated until baseline diameters were re-established (≈10 minutes).  Next, a series of 
pressure steps at 20, 40, 60, 80 and 100 mmHg were applied to each artery.  At each 
pressure, artery diameter and wall [Ca2+]i were recorded first during equilibration in 
normal PSS and then in PSS containing 120 mM K+.  Following stabilization of the 
diameter and Ca2+ responses to 120 mM K+ the arteries were returned to normal PSS 
and the arteries were re-equilibrated until initial diameters were re-established (≈10 
minutes).  The pressure was then raised to the next level and the measurements were 
repeated.  Once responses were measured at 100 mm Hg, the arteries were equilibrated in 
PSS containing zero calcium with EDTA (3 mM) to determine the maximum passive 
diameter for each artery.  This diameter was recorded at each of the previously applied 
pressure steps. 
 
Fluorescent Immunohistochemistry 
Arteries were fixed in 4% neutral buffered EM-grade formaldehyde (Electron 
Microscopy Sciences, 15713-S) overnight, and then dehydrated, embedded in paraffin, 
and cut into sections 5 µm thick.  The sections were then deparaffinized, rehydrated, 
immersed in citrate buffer at pH 6.03, and microwaved for 5 minutes to facilitate antigen 
recovery.  The sections were then incubated in 1% Bovine Serum Albumin (BSA, Santa 
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Cruz Biotechnology, SC-2323) with Triton X-100 (Sigma-Aldrich, T-8787) blocking 
buffer for an hour.  Next, the sections were double-stained with primary antibodies 
reactive with Smooth Muscle α-Actin (Sigma-Aldrich, A5228 @ 1:200), SM2 Myosin 
(Abcam, Ab53219 @ 1:500), SM1 Myosin (Abcam, Ab681 @ 1:100), and SMemb 
Myosin (Covance, PRB-445P @ 1:400), applied and incubated at 4 ºC overnight.  The 
following day, the sections were washed in PBS then equilibrated in darkness for two 
hours at room temperature with two secondary antibodies labeled with Dylight-488 and 
Dylight-649, and then examined with our Olympus FV1000 at an optical section 
thickness of 1 μm, a lateral resolution of 2 nm, and a numerical aperture of 18.  The 
degree of colocalization between the two markers was determined using the 
Colocalization Coefficient, because this measure was independent of absolute marker 
intensities.  For the colocalization analysis, coronal sections were extracted from the 
parent images using a masking routine to eliminate background contributions to the 
measurement statistics.  These methods have previously been described in detail (12, 13). 
 
Chemical and Reagents 
All chemicals were purchased from Sigma (St. Louis, MO), except pluronic acid 
and fura-2 AM which were acquired from Molecular Probes / Invitrogen.   
 
Data Analysis and Statistics 
All values are given in the text as means ± SE, and statistical significance implies 
P < 0.05 unless stated otherwise.  In all cases, n refers to the number of animals studied. 
Values of artery diameter, and wall calcium were analyzed via two-way ANOVA with 
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repeated measures using age (pup vs. adults) and pressure as factors.  Post hoc 
comparisons were performed using the Fisher Paired Least Significant Difference 
analysis.  Values for the Colocalization Coefficient were compared using a Behren’s-
Fischer analysis with pooled variance.  For analysis of myosin isoform expression, all 
image pixels with greater than median intensity for α-actin were segregated into two 
groups with intensities either above or below the median intensity for each myosin 
isoform, respectively (SM2 and SMemb).  The percentages of total pixels in each of these 
groups was calculated for each age group, and then compared between age groups using a 
Behren’s-Fischer analysis with pooled variance.  All data sets were normally distributed, 
as verified using a D’Agostino-Pearson K2 test, and homogeneity of variance within 
ANOVA was verified using a Bartlett’s-Cochran test (68). 
 
Results 
This study is based on data obtained from 15 rats: five were 8-month old adults 
from control-fed mothers; five were 8-month old adults from food-restricted mothers; and 
five were 8-month adults from food-restricted mothers treated with Metyrapone; all were 
cross-fostered from different dams to minimize any genetic or litter-specific effects.  One 
artery segment was used from each animal for contractility studies, and the contralateral 
artery was taken for immunohistochemistry and confocal imaging.  
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Effects of Changes in Pressure on Maximum Passive Diameter in Control, MFR and 
MFR +Metyrapone MCAs 
In Control arteries treated with EGTA to eliminate active tone, average diameters 
increased progressively from 220 ± 13 µm at 20 mm Hg to 296 ± 10 µm at 100 mm Hg 
(Figure 1, upper panel).  The relation between pressure and diameter was shifted upward 
in the MFR group, in which diameters averaged 243 ± 7 µm at 20 mm Hg to 299 ± 11 µm 
at 100 mm Hg.  The MFR values were significantly greater than observed in Controls at 
both 20 and 40 mm Hg.  Treatment with Metyrapone yielded a pressure-diameter relation 
that was not significantly different than that in Controls at any pressure; diameters 
averaged 228 ± 5 µm at 20 mm Hg and 299 ± 5 µm at 100 mm Hg.  At 20 mm Hg, the 
diameter in the Metyrapone group was significantly less than that in the MFR group. 
Calculations of incremental compliance from the slopes of the pressure-diameter 
relations revealed that in Control group arteries, compliance decreased progressively 
from 1.29 ± 0.25 µm/mm Hg at 30 mm Hg to 0.66 ± 0.02 µm/mm Hg at 90 mm Hg 
(Figure 1, lower panel).  The relation between compliance and pressure was significantly 
shifted downward in the MFR group such that compliance averaged 0.92 ± 0.12 µm/mm 
Hg at 30 mm Hg to 0.55 ± 0.0 µm/mm Hg at 90 mm Hg.  Treatment with Metyrapone 
yielded a pressure-compliance relation that was not significantly different than that in 
Controls at any pressure.  In the Metyrapone group, compliance values averaged 1.22 ± 
0.20 at 30 mm Hg and 0.56 ± 0.09 at 90 mm Hg. 
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Figure 1: Effects of Maternal Food Restriction on Passive Arterial Diameter and 
Compliance. Upper Panel: Passive artery diameters were determined in the presence of 3 
mM EGTA, which inhibited all active tension. Compared to arteries from the Control group 
animals, arteries in the MFR group had larger diameters at all pressures, and these 
differences were significant at 20 and 40 mm Hg (P<0.05, *).  Artery diameters in the 
Metyrapone group were not significantly different than those in the Control group at any 
pressure and were significantly less than in the MFR group at 20 mm Hg (P<0.05, #).  
Lower Panel: Calculations of incremental compliance from the slopes of the pressure-
diameter relations indicated that MFR significantly decreased compliance relative to 
Control and this effect was significant at 30 and 70 mm Hg (P<0.05, *).  Values in the 
MFR+Metyrapone group did not differ significantly from those in controls at any pressure. 
In both panels, error bars indicate SEM for N=5 at each point.  
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Effects of Changes in Pressure on Myogenic Contractility in Control, MFR and MFR 
+Metyrapone MCAs 
Stretch-induced active (myogenic) contractions were calculated at each transmural 
pressure as differences in artery diameter measured in PSS and EGTA solutions.  In 
Control arteries, these ∆D values increased from 36 ± 10 µm at 20 mm Hg to a peak 
value of 75 ± 7 µm at 60 mm Hg.  At higher pressures, the ∆D values decreased to 55 ± 7 
µm at 100 mm Hg (Figure 2, upper panel).  The ∆D values in arteries from the MFR 
group were generally less than observed in the Control group, and these differences were 
significant at 40 and 60 mm Hg.  In the MFR+Metyrapone group, the ∆D values were 
significantly less than observed in the Control group at 60 mm Hg but were greater than 
observed in Controls at 100 mm Hg. 
Stretch-induced changes in cytosolic calcium concentration were calculated at each 
transmural pressure as differences in concentration measured in PSS and EGTA 
solutions.  In Control arteries, these ∆[Ca2+] values increased from 96 ± 3 nM at 20 mm 
Hg to a peak value of 141 ± 7 nM at 80 mm Hg (Figure 2, middle panel).  The ∆[Ca2+] 
values in arteries from the MFR group were not significantly different than observed in 
the Control group at any pressure.  In contrast, the ∆[Ca2+] values observed in the 
MFR+Metyrapone group were significantly greater than observed in Control arteries at 
all pressure, and were significantly greater than observed in MFR arteries at 20, 60, 80 
and 100 mm Hg. 
Myofilament calcium sensitivity was estimated as the ratio between the stretch-
induced ∆D response and the ∆[Ca2+] response at each pressure.  The values of this ratio 
were significantly less in the MFR group than in the Control group at all pressures except 
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100 mm Hg (Figure 2, bottom panel).  Values of this ratio in the MFR+Metyrapone 
group were also significantly less than in the Control group, and at all pressures. 
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Figure 2. Effects of MFR and Metyrapone on Myogenic Pressure-Diameter Relations. 
Shown in the upper panel are stretch-induced (myogenic) changes in diameter measured in 
each of the experimental groups.  The stretch-induced ∆D responses were generally less in 
the MFR group than in controls, and these differences were significant at 40 and 60 mm 
Hg (P<0.05, *).  In the MFR+Metyrapone group, the ∆D values were significantly less than 
observed in the Control group at 60 mm Hg, but were greater than observed in Controls at 
100 mm Hg.  As indicated in the middle panel, stretch-induced changes in cytosolic 
calcium were not different in arteries from the Control and MFR groups.  In contrast, the 
stretch-induced ∆[Ca2+] values observed in the MFR+Metyrapone group were significantly 
greater than seen in Control arteries at all pressures (P<0.05, *), and were significantly 
greater than observed in MFR arteries at 20, 60, 80 and 100 mm Hg (P<0.05, #).  Shown 
in the lower panel are estimates of myofilament calcium sensitivity, calculated as the ratio 
between the stretch-induced ∆D response and the ∆[Ca2+] response at each pressure.  The 
values of this ratio were significantly less in the MFR group than in the Control group at 
all pressures except 100 mm Hg.  Values of this ratio in the MFR+Metyrapone group were 
also significantly less than in the Control group, and at all pressures.  Error bars indicate 
SEM for N=5 at each point.  
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Effects of Changes in Pressure on Potassium-Induced Contractility in Control, MFR 
and MFR +Metyrapone MCAs 
Potassium-induced active contractions were calculated at each transmural pressure 
as differences in artery diameter measured in high potassium (120 mM) and PSS 
solutions.  In Control arteries, these ∆D values did not vary with pressure and ranged 
from a minimum of 36 ± 7 µm at 100 mm Hg to a maximum of 62 ± 9 µm at 40 mm Hg 
(Figure 3, upper panel).  Potassium-induced ∆D values in arteries from the MFR group 
were significantly greater than control at 40 mm Hg, but were significantly less than 
control at 80 mm Hg.  The ∆D values in the MFR+Metyrapone group were significantly 
greater than in the Control group only at 100 mm Hg, but were significantly greater than 
in the MFR+Metyrapone arteries at both 80 and 100 mm Hg.   
Potassium-induced changes in cytosolic calcium concentration were calculated at 
each transmural pressure as differences in concentration measured in high potassium and 
PSS solutions.  In Control arteries, these ∆[Ca2+] values ranged from a maximum of 211 
± 11 nM at 20 mm Hg to a minimum of 162 ± 18 nM at 80 mm Hg (Figure 3, middle 
panel).  At all pressures, ∆[Ca2+] values were significantly greater in the MFR group than 
in the Control group and ranged from 302 ± 30 nM at 20 mm Hg to 230 ± 31 nM at 80 
mm Hg.  In the MFR+Metyrapone group, ∆[Ca2+] values were also significantly greater 
than in the Control group at all pressures, but did not differ significantly from values in 
the MFR group. 
Potassium-induced changes in myofilament calcium sensitivity were estimated as 
the ratio between the K+-induced ∆D response and the ∆[Ca2+] response at each pressure.  
Values of this ratio were significantly less in the MFR group than in the Control group at 
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20 and 80 mm Hg (Figure 3, bottom panel).  Values of this ratio in the 
MFR+Metyrapone group were significantly less than in the Control group at 20, 40 and 
80 mm Hg, but were significantly greater than in the Control group at 100 mm Hg.  
Values of this ratio in the MFR+Metyrapone group were also significantly less than in 
the MFR group at 20 and 40 mm Hg.  
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Figure 3. Effects of Changes in Pressure on Potassium-Induced Contractility in Control, 
MFR, and MFR+Metyrapone MCA’s. Shown in the upper panel are stretch-induced 
(myogenic) changes in diameter. In arteries from the MFR group, the ∆D were significantly 
greater than Control at 40 mm Hg, but were significantly less than control at 80 mm Hg 
(P<0.05, *).  In the MFR+Metyrapone arteries, ∆D values were significantly greater than 
in the Control group at 100 mm Hg (P<0.05, *) and were greater than in the 
MFR+Metyrapone at both 80 and 100 mm Hg (P<0.05, #).  Shown in the middle panel are 
potassium-induced changes in cytosolic calcium, which were significantly greater in both 
the MFR and MFR+Metyrapone groups (P<0.05, *) than in the Control group, at all 
pressures.  Values of ∆[Ca2+] in the MFR and MFR+Metyrapone groups did not differ 
significantly from one another at any pressure.  Shown in the lower panel are estimates of 
myofilament calcium sensitivity (∆D/∆[Ca2+]), which were significantly less in the MFR 
group than in the Control group at 20 and 80 mm Hg (P<0.05, *).  Values of this ratio in 
the MFR+Metyrapone group were significantly less than in the Control group at 20, 40 and 
80 mm Hg, but were significantly greater than in the Control group at 100 mm Hg.  Values 
of this ratio in the MFR+Metyrapone group were also significantly less than in the MFR 
group at 20 and 40 mm Hg (P<0.05, #).  Error bars indicate SEM for N=5 at each point. 
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Effects of Maternal Food Restriction and Metyrapone on Contractile Protein 
Colocalization and Smooth Muscle in MCAs 
To assess the effects of MFR with or without Metyrapone on smooth muscle 
phenotype, concentric rings of rat middle cerebral arteries were immunostained to detect 
colocalization of Smooth Muscle α-Actin with the Non-Muscle, SM1, or SM2 isoforms 
of myosin heavy chain (Figure 4).  Colocalization of Smooth Muscle α-Actin with the 
Non-Muscle isoform was significantly greater in the MFR group than in either the 
Control group or the MFR+Metyrapone group (Figure 5).  Colocalization of Smooth 
Muscle α-Actin with the SM1 isoform was also significantly greater in the MFR group 
than in the Control group, but the SM1 colocalization value in the MFR+Metyrapone did 
not differ significantly from either the Control or MFR groups.  For colocalization of 
Smooth Muscle α-Actin with the SM2 isoform, the values in the Control and MFR 
groups were similar, but the value in the MFR+Metyrapone group was significantly 
greater than in either the Control or MFR groups. 
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Figure 4. Effects of Maternal Food Restriction and Metyrapone on Contractile Protein 
Colocalization and Smooth Muscle in MCA’s, Composite. Concentric rings of rat middle 
cerebral arteries were fixed in 4% paraformaldehyde, cut at 5 µm, and immunostained to 
quantify colocalization of Smooth Muscle α-Actin with one of three myosin heavy chain 
isoforms.  Shown here are representative sections from all three experimental groups 
immunostained for colocalization of Smooth Muscle α-Actin with the Non-Muscle isoform 
of myosin heavy chain.  
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Figure 5. Effects of Maternal Food Restriction and Metyrapone on Contractile Protein 
Colocalization and Smooth Muscle in MCA’s, Quantitative Analysis. Colocalization of 
Smooth Muscle α-Actin with the myosin heavy chain isoforms was quantified to assess the 
effects of MFR and Metyrapone on the fraction of smooth muscle exhibiting immature 
(Non-Muscle), intermediate (SM1), or fully differentiated (SM2) contractile smooth 
muscle phenotypes.  Colocalization with Smooth Muscle α-Actin was with Non-Muscle 
myosin heavy chain was significantly greater in the MFR group than in either the Control 
group or the MFR+Metyrapone group (Figure 5).  Colocalization of Smooth Muscle α-
Actin with the SM1 isoform was also significantly greater in the MFR group than in the 
Control group, but the SM1 colocalization value in the MFR+Metyrapone did not differ 
significantly from either the Control or MFR groups.  For colocalization of Smooth Muscle 
α-Actin with the SM2 isoform, the values in the Control and MFR groups were similar, but 
the value in the MFR+Metyrapone group was significantly greater than in either the 
Control or MFR groups.  Error bars indicate SEM for N=5 for each mean. 
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Discussion 
The present study explores the hypothesis that glucocorticoids contribute to the 
effects of maternal food restriction (MFR) on structure-function relations in the cerebral 
circulation of adult offspring. In middle cerebral arteries (MCA), MFR reduced 
incremental compliance and this effect was largely prevented by treatment with 
Metyrapone, a corticosterone synthesis inhibitor. Myogenic reactivity was attenuated by 
MFR, largely through inhibition of myofilament calcium sensitivity, and this inhibition 
was resistant to Metyrapone. MFR had mixed effects on potassium-induced contractions 
that included enhancement of the calcium response to potassium together with inhibition 
of myofilament calcium sensitivity. The effects of MFR on potassium-induced tone were 
minimally altered by Metyrapone. Colocalization of Non-Muscle Myosin Heavy Chain 
(NM-MHC) with smooth muscle α-actin, an index of the proportion of functionally 
immature smooth muscle in the artery, was enhanced by MFR and this effect was 
reduced by Metyrapone. In contrast, colocalization of SM2 Myosin Heavy Chain (SM-
MHC) with smooth muscle α-actin, an index of the proportion of fully differentiated 
contractile smooth muscle, was unaffected by MFR but was enhanced by Metyrapone. 
Together, these results suggest that MFR selectively alters multiple aspects of structure-
function relations in cerebral arteries, and that only some of these effects involve the 
actions of glucocorticoids. 
One of the most well documented effects of glucocorticoids on arterial structure is 
their ability to increase stiffness (34). Given the capacity of MFR to increase maternal 
glucocorticoids (43), our first series of experiments examined if MFR could increase 
cerebral artery stiffness and thereby reduce passive compliance. These measurements 
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revealed that MFR reduced passive compliance and, more importantly, that treatment 
with Metyrapone virtually eliminated this effect (Figure 1). Given the key roles of elastin 
and collagen as determinants of arterial stiffness (60, 64), these findings suggest that 
MFR reduces cerebrovascular compliance through changes in matrix protein abundance 
and organization, mediated by increased activity of corticosterone on the glucocorticoid 
receptor (6, 42) and possibly also on the mineralocorticoid receptor (46). These results 
are also consistent with possible effects of MFR on matrix metalloproteinase (MMP) 
activities or tissue inhibitors of metalloproteinases (TIMP), as suggested by other studies 
(21, 27, 37). Although the precise mechanisms remain unclear, the results suggest that 
MFR can have long-term, “programming” effects on cerebrovascular compliance in a 
glucocorticoid-dependent manner. 
Compared to their effects on vascular structure and compliance, the long-term 
effects of glucocorticoids on vascular function are more poorly understood, due largely to 
their highly artery and tissue-specific effects (22, 25, 67). To evaluate if MFR might 
produce long-term influences on cerebrovascular contractility through a glucocorticoid 
dependent pathway, our second series of experiments assayed pressure-dependent 
myogenic contractility in cerebral arteries isolated from adult offspring of food-restricted 
dams. In these experiments, MFR depressed myogenic contractility (Figure 2, upper 
panel), but had very little effect on the relation between transmural pressure and cytosolic 
calcium concentration (Figure 2, middle panel). Because contractile tone is the product 
of cytosolic calcium concentration and myofilament calcium sensitivity (58), the 
observed pattern suggests that the long-term effects of MFR on myogenic contractility 
were attributable largely to decreased myofilament calcium sensitivity. Consistent with 
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this interpretation, MFR decreased the ratio between artery diameter and cytosolic 
calcium (Figure 2, bottom panel), an index of myofilament calcium sensitivity (12). 
Regarding the role of glucocorticoids in these “programming” effects of MFR, 
Metyrapone had very little influence on MFR-induced depression of myogenic 
contractility (Figure 2, upper panel), but interfered significantly with regulation of 
cytosolic calcium (Figure 2, middle panel). This latter finding suggests that 
glucocorticoids are essential for calcium homeostasis in cerebral arteries, at least in adult 
offspring of food-restricted dams. Although glucocorticoids can depress contractility in 
cerebral arteries (19), and can inhibit myofilament sensitivity in airway smooth muscle 
(23) and uterine arteries (66), Metyrapone had very little effect on myofilament calcium 
sensitivity in cerebral arteries of MFR offspring (Figure 2, bottom panel). Altogether, 
these findings suggest that MFR attenuates cerebrovascular myogenic contractility 
through long-term depression of myofilament calcium sensitivity via mechanisms largely 
independent of glucocorticoids. 
Another important characteristic of vascular function is maximum contractile 
capacity, which can be elucidated by exposure to high concentrations of potassium that 
depolarize the smooth muscle membrane, enable the influx of extracellular calcium, and 
maximally stimulate the contractile apparatus in a receptor-independent manner (32). In 
our experiments, MFR produced long-term effects on contractile responses to potassium 
depolarization in a pressure-dependent manner (Figure 3) that were quite distinct from 
the pattern observed for myogenic contractility (Figure 2). Compared to control 
responses, MFR responses to potassium depolarization were elevated at 40 mm Hg, but 
depressed at 80 mm Hg, suggesting that the fundamental stress-strain relationship in 
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these arteries underwent long-term alteration by MFR. These results at lower transmural 
pressures (20 – 60 mm Hg) generally agreed with the findings of Ozaki et al. (55), who 
reported that MFR enhanced potassium-induced contractility of isolated femoral arteries. 
In turn, the inconsistencies between the present results at higher pressures and the Ozaki 
findings could be due to differences in artery type (femoral vs. cerebral), method of 
contractile measurement (pressurized myography vs. wire-mount isometric myography), 
or food-restriction model (70% MFR for 0-18 days gestation vs. 50% MFR for 11-21 
days gestation). 
Unlike the Ozaki study, however, the present experiments examined the sustained 
effects of MFR on calcium regulation and revealed that MFR increased cytosolic calcium 
concentrations at all pressures, suggesting that the long-term effects of MFR on overall 
contractility were not dependent primarily upon pressure-dependent changes in calcium 
handling (Figure 3, middle panel). Instead, the data suggest that MFR increased either 
release or influx of calcium or, alternatively, decreased extrusion or sequestration of 
calcium in these arteries (45). The contractile effects of the elevated calcium levels in the 
arteries from the MFR offspring were partially offset by parallel depression of 
myofilament calcium sensitivity between 20 and 80 mm Hg (Figure 3, lower panel). The 
ability of MFR to modulate myofilament sensitivity further suggests that MFR either 
decreased the ratio between Myosin Light Chain Kinase and Myosin Light Chain 
Phosphatase activities (thick filament regulation), and/or depressed the ability of 
activated myosin heavy chain to generate force through cross-bridge interactions with 
actin (thin filament regulation) (53). Altogether, these results suggest that MFR can exert 
long-term effects on either calcium regulation through possible alterations in the function 
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of key proteins such as L-channels, PMCA, or SERCA, or alternatively may modulate 
abundances and activities of proteins governing myofilament calcium sensitivity such as 
MLCK, MLCP, CPI-17, Rho-Kinase, caldesmon, HSP27, etc. (3, 11). 
One of the possible mechanisms through which MFR could modulate multiple key 
vascular proteins is through activation of glucocorticoid receptors (19, 40, 49). Consistent 
with a role for glucocorticoids in MFR-induced changes in contractility, Metyrapone 
blocked the effects of MFR on potassium contractions at low (40 mm Hg) and high (80 
mm Hg) pressures (Figure 3, upper panel). Despite these effects of Metyrapone on 
potassium-induced contractility, Metyrapone had no significant effect on cytosolic 
calcium, suggesting that glucocorticoids are not involved in the programmed effects of 
MFR on calcium handling during potassium contractions (Figure 3, middle panel). This 
result agrees with previous findings in cardiac myocytes that L-channel density is 
increased, and that SERCA pump abundance is decreased by glucocorticoids (15), 
leading to increased cytosolic calcium concentrations. In contrast, Metyrapone further 
depressed myofilament calcium sensitivity at low pressures (20 and 40 mm Hg), but 
increased it at high pressure (100 mm Hg) in potassium-contracted arteries, suggesting 
that glucocorticoids probably contribute little to the long-term effects of MFR on calcium 
sensitivity (Figure 3, lower panel). In combination, these results emphasize that MFR 
influences calcium handling and calcium sensitivity very differently in stretch-induced 
and potassium-induced contractions through mechanisms that are largely independent of 
the sustained effects of glucocorticoids. 
Another general mechanism through which MFR could alter cerebrovascular 
contractility is by modulation of the phenotype of smooth muscle (54) in cerebral arteries. 
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A transition from a contractile to a non-contractile smooth muscle phenotype can 
dramatically alter calcium handling, contractility and structure (28, 65), and such 
dedifferentiation can be identified through changes in patterns of contractile protein 
expression and colocalization (1, 12, 30). From this perspective, MFR produced long-
term increases in the fraction of smooth muscle α-actin colocalized with Non-Muscle 
Myosin Heavy Chain (NM-MHC)(Figure 4), suggesting an increase in the fraction of 
non-contractile smooth muscle (20, 54). This result suggests that MFR could promote 
either inward migration of progenitor smooth muscle cells, or dedifferentiation and/or 
proliferation of pre-existing contractile smooth muscle (56). Arguing against 
dedifferentiation, which would be expected to decrease the number of contractile smooth 
muscle cells, MFR had no effect on the colocalization of SM2 MHC with smooth muscle 
α-actin, suggesting that the proportion of contractile smooth muscle cells was unchanged 
(Figure 5). In addition, the colocalization of SM1 MHC with smooth muscle α-actin, 
which is an indicator of partially differentiated contractile smooth muscle (20), was 
increased by MFR. Together, these findings suggest that MFR produced long-term 
increases in the total fractions of smooth muscle cells in both the contractile and non-
contractile phenotypes, which could be explained only by proliferation of existing smooth 
muscle, or inward migration and/or differentiation of smooth muscle progenitors in the 
artery wall (54). 
With respect to the involvement of glucocorticoids in the effects of MFR on smooth 
muscle phenotype, treatment with Metyrapone significantly decreased colocalization of 
NM-MHC with smooth muscle α-actin (Figure 5). This finding suggests that 
glucocorticoids contributed to the MFR-induced increases in colocalization of NM-MHC 
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with smooth muscle α-actin, which again could indicate inward migration of progenitor 
smooth muscle cells, dedifferentiation, or smooth muscle proliferation (56). Whereas 
Metyrapone had minimal effects on SM1 colocalization, it significantly enhanced 
colocalization of SM2 MHC with smooth muscle α-actin, which supports the view that 
glucocorticoids promote contractile dedifferentiation in response to MFR. This 
interpretation is in contrast with previous reports that antenatal dexamethasone treatment 
can accelerate short-term vascular differentiation (26), and emphasizes that short-term 
and long-term effects of glucocorticoids are not always equivalent.  On the other hand, 
the present results agree with previous reports that glucocorticoids promote proliferation 
in vascular smooth muscle cells (63), and thereby could contribute to the long-term 
effects of MFR on smooth muscle phenotype. These changes in smooth muscle 
phenotype, in turn, could help explain the complex effects of MFR on calcium handling, 
myofilament calcium sensitivity, and overall contractility. 
Overall, the present experiments support the hypothesis that early maternal food 
restriction fundamentally alters long-term structure-function relationships in the middle 
cerebral arteries of adult offspring, as revealed by pressure myography and confocal 
microscopy. MFR significantly decreased compliance in offspring cerebral arteries, and 
this effect was rescued by treatment with the corticosterone synthesis inhibitor 
Metyrapone, suggesting that this effect of MFR was mediated by increased 
glucocorticoid exposure during gestation. MFR also caused long-term depression of 
myogenic reactivity due largely to attenuation of myofilament calcium sensitivity through 
mechanisms that were resistant to Metyrapone, and thus appeared independent of 
glucocorticoids. Similarly, MFR programmed potassium-induced contractions but in a 
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manner distinct from its effects on myogenic contractility; potassium contractions were 
enhanced at low pressure, and depressed at high pressure, by MFR. During potassium 
contractions, MFR increased cytosolic calcium at all pressures through mechanisms 
resistant to Metyrapone, but MFR generally depressed myofilament calcium sensitivity 
through mechanisms that were enhanced by Metyrapone at low pressures, but 
antagonized at high pressures. In relation to smooth muscle phenotype, MFR gave rise to 
enhanced proportions of cells in a non-contractile phenotype without diminishing the 
proportion of fully differentiated contractile cells, suggesting either a long-term shift 
towards an increased proliferation or inward migration of smooth muscle progenitors. 
Metyrapone generally antagonized the effects of MFR on smooth muscle phenotype, 
suggesting that glucocorticoids contribute to changes in smooth muscle phenotype in 
both the long term as well as the short term. Owing to the strong relationships among 
smooth muscle phenotype, contractility, and structure, the sustained influences of MFR 
on smooth muscle phenotype help explain both the glucocorticoid-dependent and –
independent general effects of MFR programming on cerebrovascular structure and 
function.  These findings tempt speculation that MFR might increase vulnerability to 
stroke and other cerebrovascular diseases, in parallel with its ability to increase the risk of 
cardiac disease in adult offspring of food-restricted mothers (7, 8). 
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Abstract 
 Neonatal stroke continues to present a major risk for infants. The present study 
explores the hypothesis that prenatal programming via gestational glucocorticoid 
inhibition results in permanent changes to cerebrovasculature structure and function 
during postnatal life, which fundamentally alters vascular response to a mild ischemic 
stroke. Pregnant female rats were administered 0.5 mg/ml Metyrapone (MET), a 
glucocorticoid synthesis inhibitor, from Day 11 to Day 21 of gestation. At postnatal day 
9/10, pups (n=6 per group) were taken for unilateral carotid ligation. Twenty-four hours 
later, the pups were then exposed to 90 minutes of 8% oxygen to induce a mild hypoxic-
ischemic insult. At postnatal day 11/12, middle cerebral arteries were harvested for 
analysis by confocal microscopy and vessel-bath myography. Mild hypoxia-ischemia 
significantly increased plasma corticosterone levels by 2-fold, increased passive arterial 
diameter by ~20%, and decreased colocalization of NM-MHC with α-actin by 4%. 
Gestational MET either had no effect or reversed many of these changes, suggesting a 
possible protective role of glucocorticoid inhibition during gestation. These results 
indicate that the cerebrovasculature may be an early indicator of mild ischemic injury and 
may provide a potential target for future therapeutics.  
 
Introduction 
Neonatal stroke occurs at a rate of about 1 in 4000 live births (1), and the 
estimated mortality rate for neonates is around 3.49/100,000 annually (34). In the United 
States, within the first five years of life, the cost of care per neonatal stroke patient can 
total more than $50,000 (18). As with adult stroke, neonatal stroke victims may suffer 
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from permanent cognitive impairment, leading to lifelong disability. Despite years of 
research, the care and treatment for sufferers of hypoxia-ischemia remains largely 
unchanged and progress has been disappointing, with clinical trials failing to show 
efficacy despite promise in animal models (37).  
Though the underlying cause of the lack of treatment options are multifactorial 
and complex, the data presented in this paper will focus on three major concerns. First, 
animal models of hypoxia-ischemia encephalopathy (HIE) may not be as clinically 
relevant as hoped. Second, current models of HIE may emphasize neuronal damage at the 
expense of other tissues such as the cerebral blood vessels. Third, many studies may not 
have accounted for risk factors associated with neonatal stroke such as the possible 
contributions of gestational programming and early life environment. Hence, the 
following study presents the hypothesis that the vasculature may be one of the key 
mediators of neonatal hypoxia-ischemia and that programming of the long-term stress 
response via glucocorticoid inhibition may be instrumental in modulating this response.  
One of the key challenges in neonatal stroke research is the development of an 
appropriate model of HIE. Prior research has demonstrated that the neonatal brain is very 
resistant to hypoxia. In most cases, hypoxia alone does not seem to be enough to cause 
ischemic injury in most cases (26). Hence, the development of specific models of HIE 
injury have been required. One well-characterized method of studying HIE is the Rice-
Vannucci model, which was originally developed by Levine in the 1980’s (40). The 
procedure involves unilateral surgical ligation of the carotid artery followed by 8% 
oxygen (hypoxia) for 3.5 hours. Histological characterization of the model revealed 
moderate to severe neuronal changes with a mortality rate of around 20%. Subsequent 
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studies have modified the HIE model, with the majority reporting rates of around 20-30% 
infarction (4, 5). For a variety of reasons, however, these moderate to severe infarcts may 
not be representative of the actual clinical picture, as infarcts above 10% in humans are 
associated with severe disability and poor clinical outcomes (17). Frequently, neonatal 
stroke is not characterized by easily diagnosable symptoms such as epilepsy or sidedness. 
Instead, a more accurate picture may be one where mild symptoms such as lethargy or 
muscle weakness go undetected and undiagnosed until months later, prompting a 
retroactive diagnosis of perinatal stroke (30, 49). As such, a model of mild hypoxia-
ischemia may be better match (33, 39, 47, 48).  
Another key limitation of current neonatal stroke research is that much of the 
literature is focused on neurons. This is understandable as neuronal tissue is very 
metabolically sensitive and there is a well-established correlation between the severity of 
neuronal cell death and subsequent neurological damage (17). The main lesion may 
indeed be exacerbated by lethal levels of Ca++ and neurotransmitters (i.e. excitotoxicity), 
and selective vulnerability may exist in certain sections of the brain regardless of their 
perfusion status (26).  However, neuroprotective strategies alone may not be enough, and 
non-neuronal mechanisms may be at play. If true, then viewing stroke from a 
neurovascular perspective may be helpful (3). There is evidence, for example, that 
neuronal damage can be thought of as a consequence of a failed or inadequate vascular 
response or impaired neurovascular response (45). The myogenic response, which serves 
primarily to prevent hypo- or hyper-perfusion of downstream tissues, is an important 
factor in determining what the brain ultimately “sees” during an infarct and may play a 
key role in stroke (6, 15, 25). Healthy blood vessels with healthy vascular smooth muscle 
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cells that allow for appropriate contractility are critical to neuronal health and overall 
brain health. How a vessel responds to any given stimulus is also dependent on a 
multitude of factors including the different phenotypes of its corresponding smooth 
muscle cells (38). In the developing postnatal animal, we have previously reported that a 
smaller number of contractile SMCs are doing the majority of the force generation (11), 
such that any changes to the cell equilibrium may be detrimental to the brain’s perfusion 
status. Vessel growth or pruning may also play a role in overall brain health, and 
angiogenesis should not be ruled out (3).  
Finally, data from animals from otherwise healthy or unperturbed pregnancies 
may not fully take into account risk factors commonly associated with clinical stroke. 
While a severe stroke model may be relevant to acute birth-related trauma such as 
asphyxia, it may fall short of explaining the clinical picture in the presence of prenatal 
programming. Among the factors that influence birth outcomes and brain development, it 
is thought that prenatal glucocorticoid (GC) exposure plays a key role (9). 
Dexamethasone and other synthetic glucocorticoids have been shown to cause a number 
of long-term programming changes such as high blood pressure. GC therapies have even 
been shown to increase adult stroke risk (14). Timing of GC administration appears to 
play a critical role. However, to date, most studies have focused on acute administration 
of glucocorticoids as opposed to chronic or sustained exposure, and fewer still have 
looked at the gestational effects of glucocorticoid inhibition (31). Therefore, the current 
study sought to investigate whether inhibition of glucocorticoid effects during gestation 
might produce a desirable effect postnatally and how early programming of the 
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hypothalamic pituitary adrenal (HPA) axis might affect the animal’s response to a 
subsequent ischemic insult. 
All in all, the purpose of this study is to characterize the effects of gestational 
glucocorticoid inhibition on cerebrovascular structure and function within the context of 
a model of mild hypoxia-ischemia.  
 
Materials and Methods 
General Preparation 
All experimental procedures were approved by the institutional Animal Use and 
Care Committee at Loma Linda University. First-time-pregnant Sprague-Dawley rats 
(Charles River Laboratories, Hollister, CA; Envigo Laboratories, Placentia, CA) were 
housed at constant temperature and humidity with a 12:12-h:light-dark cycle with food 
and water ad libidum. At day 11 of gestation until term (21 days), Metyrapone (M2696 at 
0.5 mg/ml; Sigma, St. Louis, MO) was dissolved in drinking water.  The water was 
changed out daily, and the dose was based on previous studies showing effective 
blockage of maternal corticosterone synthesis (42). Water consumption was monitored 
daily and did not differ from Control dams, which received standard filtered water. The 
rats were allowed to deliver spontaneously, and pups were kept with their dams until the 
day of surgery. 
On postnatal days 9-10, two male pup litter-mates were randomly selected to 
undergo surgery. Male pups were chosen as sex differences have been previously 
demonstrated and HIE typically develops more severely in male vs. female pups (36). 
One animal was anesthetized with isoflurane and underwent unilateral carotid ligation 
64 
using 5-0 surgical silk (Ischemia surgery), while the other underwent Sham surgery 
where the carotid was dissected but not ligated. Surgical times were kept consistent 
between both Sham and Ischemia animals in order to account for the potential 
neuroprotective effects of isoflurane exposure (8). Following surgery, pups were allowed 
to recover with their dam. At 24 hours post-surgery, the Ischemia group pups were then 
placed into a hypoxia chamber maintained at 8% oxygen balanced with nitrogen (heated 
to 37 ºC) for 90 minutes. Oxygen levels in the chamber were monitored via an oxygen 
meter. At the end of the hypoxia exposure, pups were allowed 15 minutes to recover 
under normoxic conditions (room air) before they returned to their dam. Sham animals 
were placed into a separate temperature-controller chamber under normoxic conditions 
for the same duration. 
The overall study design included four groups of Sprague-Dawley rats: 1) Sham-
operated animals (Sham), 2) Ischemia animals that underwent carotid ligation surgery 
followed by hypoxia (Ischemia), 3) Sham animals that were administered Metyrapone 
during gestation (Sham+MET), and 4) Ischemia animals that received Metyrapone during 
gestation (Ischemia+MET). At postnatal days 11-12, all pups were weighed, anesthetized 
with 100% CO2 (1 minute) and then decapitated. The brains were rapidly removed and 
placed in ice-cold physiological salt solution (PSS) containing (in mM): 130 NaCl, 10.0 
HEPES, 6.0 glucose, 4.0 KCl, 4.0 NaHCO3, 1.8 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, and 
0.025 EDTA, at pH 7.4. The main branch of the middle cerebral artery (MCA) was taken 
beginning at its origin next to the Circle of Willis, cleaned of all connected tissue, cut into 
length of 3-5 mm, and then mounted on glass cannulas on a CH-1 vessel-chamber 
positioned on the stage of an inverted microscope (Living Systems, Burlington, VT). The 
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proximal cannula was connected to a pressure transducer and a windkessel reservoir of 
PSS, used to precisely set and change the transmural pressures of the arteries. The distal 
cannula was connected to a Luer-lock valve that was opened to gently flush the lumen 
during the initial equilibrium. Vessel viability was confirmed by the presence of 
contraction to high K+ solution. After subsequent equilibration, the outflow valve was 
closed, and all measurements were conducted under stop-flow conditions. Arterial 
diameters were recorded with the SoftEdge Acquisition Subsystem (IonOptix, Milton, 
MA). All methods used in this study have been previously described in detail (11, 12). 
 
Measurement of Smooth Muscle Calcium Concentration 
Once cannulated and equilibrated at 21 ºC, the artery segments were loaded with 
Fura-2 AM (ThermoFisher Scientific, Waltham, MA) for 20 minutes at a concentration of 
1 uM, as previously described (11, 12). After loading, the arteries were washed with PSS, 
and the bath temperature was increased to 37 ºC. Photons emitted at 510 nm were 
detected at a sample rate of 3 Hz using an IonOptix photomultiplier system that 
automatically corrects for background fluorescence. Kd values obtained from separate in 
vitro calibrations were used to convert the experimental fluorescent ratios (R) to [Ca2+]i 
over the physiological range by iterative fit to the Grynkiewicz equation: [Ca2+]i = Kd[(R-
Rmin)/(Rmax-R)]Sf (20). Our calculations using this equation employed the following 
averaged values: Sf (5635), Rmin (0.468), Rmax (6.837), Kd (251 mM). 
 
66 
Fluorescent Immunohistochemistry 
Arteries were fixed in 4% neutral buffered EM-grade formaldehyde (Electron 
Microscopy Sciences, 15713-S) overnight, and then dehydrated, embedded in paraffin, 
and cut into sections 5 µm thick. The sections were then deparaffinized, rehydrated, 
immersed in citrate buffer at 6.03, and microwaved for 5 minutes to facilitate antigen 
recovery. The sections were then incubated in 1% BSA (SC-2323; Santa Cruz  
Biotechnology, Santa Cruz, CA), with Triton X-100 (T-8787; Sigma-Aldrich) blocking 
buffer for hour and a half. Next, the sections were double-stained with primary antibodies 
reactive with smooth muscle ɑ-actin (A5228 @ 1:600; Sigma-Aldrich), smooth muscle 2 
(SM2) myosin (Ab53219 @ 1:400; Abcam, Cambridge, MA), and SMemb myosin 
(Poly19099 @ 1:300; BioLegend, San Diego, CA), applied and incubated at 4 ºC 
overnight. The following day, the sections were incubated for two hours at room 
temperature with two secondary antibodies labeled with Dylight-488 and Dylight-633, 
and then examined with our Olympus FV1000 confocal microscope at an optical section 
thickness of 1 µm, a lateral resolution between 146 and 185 nm, an axial resolution 
between 545 and 693 nm, and a numerical aperture of 1.4. 
Confocal images of coronal artery sections were analyzed using Image-Pro (v5.9; 
Media Cybernetics, Silver Spring, MD) and the degree of colocalization was calculated 
using data obtained from CoLocalizer Pro (Version 2.6.1, CoLocalization Research 
Software). For the colocalization analysis, coronal sections were extracted from the 
parent images via Adobe Photoshop (Version CS6; Adobe Systems, San Jose) using a 
masking routine to eliminate background contributions to the measurement statistics. 
These methods have previously been described in detail (11, 12). 
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ELISA 
Whole trunk blood was collected at the time of sacrifice into MiniCollect Lithium 
Heparin blood collection tubes (Greiner Bio-One, Kremsmunster, Austria). Blood was 
collected between the hours of 10 AM-12 PM; the times were kept consistent in order to 
account for any variability due to circadian rise and fall of corticosterone levels. The 
blood was then centrifuged at 2000 RPM at 4 ºC for 15 minutes to separate the plasma, 
and then aliquoted out and frozen at -20 ºC. In order to release any corticosterone bound 
by protein, each plasma sample was treated with perchloric acid (HClO4) followed by 
KOH, and an ethyl acetate extraction was performed using a speed vacuum (SPD 121P-
115). Corticosterone levels were then measured with an ELISA kit (ADI-900-097, Enzo 
Life Sciences). Samples were read using a Gen5 1.11 BioTek microplate reader.  
 
Chemicals and Reagents 
All of the chemicals and reagents used in this study were from Sigma-Aldrich (St. 
Louis, Missouri) or Thermo Fischer Scientific (Waltham, Massachusetts), unless 
otherwise noted.  
 
Data Analysis and Statistics 
 All values are given in the text as means ± SE, and statistical significance implies 
P < 0.05 unless stated otherwise.  In all cases, n refers to the number of animals studied. 
Values of artery diameter, and wall calcium were analyzed via two-way ANOVA with 
repeated measures using treatment (Sham vs Ischemia) or Metyrapone status (+/- MET) 
and pressure as factors. Post hoc comparisons were performed using the Fisher Paired 
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Least Significant Difference analysis.  Values for the Colocalization Coefficient were 
compared using a Behren’s-Fischer analysis with pooled variance.  For analysis of 
myosin isoform expression, all image pixels with greater than median intensity for α-
actin were segregated into two groups with intensities either above or below the median 
intensity for each myosin isoform, respectively (SM-MHC, SMemb).  The percentages of 
total pixels in each of these groups was calculated for each age group, and then compared 
between age groups using a Behren’s-Fischer analysis with pooled variance.  All data sets 
were normally distributed, as verified using a D’Agostino-Pearson K2 test, and 
homogeneity of variance within ANOVA was verified using a Bartlett’s-Cochran test 
(50). 
 
Results 
This study is based on data obtained from litters of rat pups from four distinct 
treatment groups; Sham and Ischemia animals whose mothers received normal drinking 
water, as well as Sham+Metyrapone and Ischemia+Metyrapone animals whose mothers 
received 0.5 mg/ml of Metyrapone during days 11 through 21 of gestation. Left and right 
artery segments from each animal (n=6 per group) were used for contractility studies, and 
two adjacent artery segments were taken for immunohistochemistry and confocal 
imaging. A separate set of animals (n=5 per group) were taken for in vivo MRI, 
transcardially perfused. The brains were then removed, cut into sections, and then stained 
for a number of markers including FluoroJade-C, c-fos, IBA-1, and GFAP. 
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Plasma Corticosterone in a Model of Mild Hypoxia Ischemia 
Plasma corticosterone levels were measured from samples of whole trunk blood 
collected at age P11/P12 upon sacrifice 24 hours post-hypoxia (48 hours post-surgery). 
Samples were extracted using an ethyl acetate protocol and processed with an ELISA kit. 
Results were calculated based on a standard curve of varying levels of corticosterone that 
was run concurrently with the samples. All samples were run in duplicate. Corticosterone 
levels from Ischemia animals (3000 ± 1416 pg/ml) were significantly greater than Sham 
(1553 ± 650 pg/ml) animals by ~2-fold. Samples from Ischemic animals gestationally 
treated with Metyrapone (Ischemia+MET) (1638 ± 1093 pg/ml) were not significantly 
different than levels from Sham+Metyrapone animals (1257 ± 108 pg/ml). This data was 
collected from n=4 animals per group.   
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Figure 1. Plasma Corticosterone Levels in a Model of Mild Ischemia. Presented above is 
data from n=4 animals per group. In Figure 1, plasma corticosterone levels were measured 
from samples collected from pups at various time points. All samples were extracted using 
an ethyl acetate protocol and processed with an ELISA kit. Figure 1A shows a time course 
showing plasma corticosterone levels 0, 2, 26, and 48 hours post-surgery (Note: 0-hours 
post-surgery animals were treatment-naïve). Two hours post-surgery, Ischemic animals 
showed increased plasma corticosterone levels compared with Ischemic animals whose 
dams were exposed to MET during gestation. At 26 hours, this trend was reversed. It was 
found that plasma corticosterone levels of Ischemic animals were significantly lower than 
in Sham animals. There were no significant differences between Sham vs. 
Sham+Metyrapone. Figure 1B shows plasma corticosterone levels from all four treatment 
groups at the 48 hour mark. Ischemia plasma corticosterone levels were increased ~2-fold, 
compared with Sham. There were no differences between Sham and Sham+MET groups.  
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Effects of Changes in Pressure on Maximum Passive Diameter and Compliance in 
Sham, Ischemia, Sham+Metyrapone and Ischemia+Metyrapone Pup MCAs 
In Sham arteries exposed to EGTA, there was an increase in maximum passive 
diameter from 165 ± 5 µm at 20 mm Hg to 186 ± 4 µm at 80 mmHg (Figure 2, upper left 
panel). There was also an upward shift in the maximum passive diameter in Ischemia 
arteries, ranging from a diameter of 194 ± 8 µm at 20 mm Hg and 207 ± 7 µm at 80 mm 
Hg. Ischemia artery passive diameters were significantly higher than Sham arteries at 20 
mm Hg, 40 mm Hg, and 60 mm Hg of pressure. With respect to Metyrapone treated 
arteries, we saw an increase of passive diameters from 179 ± 6 µm at 20 mm Hg to 190 ± 
6 µm at 80 mm Hg (Figure 2, upper right panel). Ischemia+MET arteries showed a slight 
upward shift compared to Sham+Metyrapone arteries, starting at  189 ± 6 µm at 20 mm 
Hg and reaching a maximum of 203 ± 7 µm at 80 mm Hg. This effect only reached 
statistical significance at 80 mm Hg. Sham and Sham+Metyrapone arteries differed 
significantly at low pressures (20, 40, and 60 mm Hg), with Sham+Metyrapone arteries 
trending to high maximum passive diameters. 
Average values of arterial compliance (Figure 2, lower panels), calculated as the 
derivative of the relation between passive diameter and pressure (Figure 2, upper panels), 
ranged from 0.18 % diameter / mm Hg at 20-40 mm Hg to 0.07 % diameter / mm Hg at 
60-80 mm Hg. All groups showed a downward sloping pattern with the least compliance 
(% diameter / mm Hg) at 60-80 mm Hg. With respect to Sham vs Ischemia arteries, there 
were significant differences at 40-60 mm Hg with Sham arteries having a compliance of 
0.080 ± 0.013 % diameter / mm Hg vs. Ischemia with 0.051 ± 0.009 % diameter / mm 
Hg, as well as at 60-80 mm Hg with 0.79 ± 0.022 % diameter / mm Hg for Sham and 
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0.042 ± 0.008 % diameter / mm Hg for Ischemia. With respect to Sham+Metyrapone vs. 
Ischemia+Metyrapone arteries, we saw no significant differences at 20-40 and 40-60 % 
diameter / mm Hg, but we did see a significant difference at 60-80 mm Hg with 
Sham+Metyrapone arteries showing an average compliance of 0.042 ± 0.008 % diameter 
/ mm Hg and Ischemia + Metyrapone arteries showing a compliance of 0.064 ± 0.008 % 
diameter / mm Hg.  Sham+MET arteries were significantly less compliant compared with 
Sham arteries  at 60-80 mm Hg, with Sham arteries showing a compliance of 0.079 ± 
0.013 % / mm Hg vs 0.073 ± 0.009 % / mmHg for Sham+MET arteries. Overall, 
Ischemia appeared to raise maximum passive diameters and to decrease compliance. 
Treatment with Metyrapone increased passive diameters at low pressures and compliance 
at high pressure. When MET animals were exposed to Ischemia, MET did not exacerbate 
the increase in diameters seen in Control Ischemic arteries.  
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Figure 2. Passive Diameter and Incremental Compliance in Ischemia and MET arteries. 
After incubation in 3 mM EGTA solution to eliminate all active tone, passive diameters 
increased with intraluminal pressure in all groups (Upper Panels). At low pressures (20 
mm Hg, 40 mm Hg, and 60 mm Hg), diameters in Ischemia arteries were greater than in 
Sham arteries (Upper Left Panel). By contrast, Sham+MET and Ischemia+MET arteries 
did not differ significantly except at 80 mm Hg, indicating that Metyrapone eliminated 
most of the differences between Sham and Ischemia. Sham vs Sham+MET arteries differed 
at low pressures (20 mm Hg, 40 mm Hg, 60 mm Hg), indicating a treatment effect of MET 
(Upper Right Panel). When the slopes of the normalized diameter to pressure (incremental 
compliance) were calculated, compliance decreased for all arteries with increasing pressure 
(Lower Panels). Between 40-60 mm Hg and 60-80 mm Hg pressure, Ischemia arteries were 
significantly less compliant than Sham arteries (Lower Left Panel). In animals treated with 
0.5 mg/ ml MET during gestation, this trend was eliminated between 40-60 mm Hg 
pressure and reversed between 60-80 mm Hg, with Ischemia+Metyrapone arteries showing 
greater incremental compliance than Sham+Metyrapone arteries (Lower Right Panel). 
Sham and Sham+MET arteries differed at 60-80 mm Hg, indicating a treatment effect at 
high pressures. Error bars indicate SEM for n values of 6 in all groups. Asterisks (*) 
indicate significant differences (p < 0.05) between Sham and ICH groups at corresponding 
pressures, while daggers (†) indicate differences between Sham and Sham+Metyrapone 
groups. 
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Changes in Diameter, Calcium, and Calcium Sensitivity Induced by Pressure and K+ in 
Pup MCAs 
Pressure-induced changes in diameter (ΔD) were calculated as the difference in 
transmural diameter in arteries in 3 mM EGTA solution (passive tone) minus the 
diameter in PSS (active tone). Plots of these values vs pressure were used to calculate the 
area under the curve. The results of these calculations are shown in Figure 3 (upper left 
panel). No significant differences were observed between any of the four groups with 
regards to pressure-induced contractions. As before with PSS-induced contractions, 
potassium-induced ΔD was measured as the difference in diameter in PSS + 120 mM 
KCl vs in 3 mM EGTA solution. Plots of these values versus intraluminal pressure were 
used to calculate the area under the curve. As shown in Figure 3 (upper right panel), the 
only significant differences seen were between Control vs Ischemia+MET group arteries, 
with Ischemia+MET arteries showing significantly depressed potassium-induced 
contractions compared with control Ischemia arteries by about 37% indicating an effect 
of the gestational MET-treatment on Potassium-induced contractility.  
Pressure-induced changes in wall calcium were calculated as the percent 
difference between wall calcium in PSS and wall calcium in 3 mM EGTA solution. Plots 
of these values versus intraluminal pressure (Δ Wall Calcium-Pressure) were used to 
calculate the area under the Δ Calcium curve, the results of which are shown in Figure 3 
(middle left panel). In Ischemia arteries, we saw a significant increase in pressure-
induced changes in wall calcium by 8.2% (middle left panel). This effect was absent in 
animals treated with Metyrapone during gestation. As with pressure-induced changes in 
wall calcium, potassium-induced changes in wall calcium were calculated as the percent 
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difference in wall calcium of arteries in PSS + 120 mM KCl vs. 3 mM EGTA solution. 
As before, the plot of these values against pressure (Δ Wall Calcium-Pressure) was used 
to calculate the area under the curve for potassium-induced contractions. As shown in 
Figure 3 (middle right panel), Ischemia significantly increased potassium-induced 
calcium contraction by 11.5% compared with Sham arteries. Arteries treated with 
Metyrapone from both the Sham and Ischemia groups showed no significant differences, 
indicating that the differences in potassium-induced contractions seen in Sham vs 
Ischemia arteries was absent following Metyrapone treatment during gestation. 
The contractile force generated by smooth muscle can be calculated from the 
product of cytosolic calcium concentration and myofilament calcium sensitivity 
(Contractile Force = Ca++ x Ca++ Sensitivity). By taking the ratio of Δ Diameter to Δ Wall 
Calcium, as calculated individually at each pressure step, a step-wise estimate of the 
calcium sensitivity can be determined. Plots of the Calcium Sensitivity (ΔD/ΔWall 
Calcium-Pressure) were used to calculate the area under the curve. The results of these 
calculations are shown in Figure 3 (bottom left panel). We did not find any significant 
differences between either Sham vs Ischemia or in arteries from Metyrapone-treated 
pups, though there was a significant difference between Sham vs Sham+MET arteries, 
with Sham+MET showing a depression of calcium sensitivity by 34.7%. Similarly, the 
plot of ΔD/ΔWall Calcium vs. Pressure for K+-induced contractions was used to generate 
the area under the curve for each pressure step. As before, we did not see any significant 
differences between any groups, Sham or Ischemia, with or without Metyrapone. We also 
did not see any significant differences between Sham vs Sham+MET, though there was a 
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significant decrease in Potassium-induced calcium sensitivity between Ischemia vs 
Ischemia+MET groups, likely indicating programming effects by Metyrapone.   
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Figure 3. Changes in Diameter, Calcium, and Calcium Sensitivity Induced by Pressure and 
K+ in Ischemia and MET arteries. Pup middle cerebral artery contractility was assessed by 
measuring changes in response to increasing intraluminal pressures (left panels) an in PSS 
with 120 mM K+ (right panels). Three main parameters were measured, including 
transmural pressure (Δ Diameter), wall calcium concentration (Δ Wall Calcium), and 
calcium sensitivity (Δ Diameter / Δ Wall Calcium), the ratio of diameter to wall calcium.  
All responses were measured vs intraluminal pressure and the area under the curve (AUC) 
was calculated for statistical comparison purposes. Here we show the area under the curve 
for Δ Diameter vs Pressure (Upper Panels), Δ Wall Calcium vs Pressure (Middle Panels), 
and Δ Diameter / Δ Wall Calcium (Lower Panels).  Neither untreated nor Metyrapone-
treated arteries showed any significant differences in the Δ Diameter responses (Upper 
Panels). Ischemia significantly increased Δ Wall Calcium when compared with Sham 
arteries, while this trend was reversed in arteries exposed to K+-induced contractions 
(Middle Panels). With respect to Metyrapone, we saw no significant differences in either 
Pressure-Induced or K+-induced contractions, though like Ischemia arteries, there was a 
significant increase compared to Sham arteries with Pressure, and a decrease during 
Potassium-induced contraction. There were no significant Sham vs Ischemia differences in 
the responses of myofilament calcium sensitivity in either Control or MET arteries. 
Asterisks (*) indicate significant differences (p < 0.05) between Sham and ICH groups at 
corresponding pressures, while daggers (†, ‡) indicate differences between Sham and 
Sham+Metyrapone groups, and Ischemia vs Ischemia+Metyrapone, respectively. 
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Effects of Ischemia ± Metyrapone on Markers of Smooth Muscle Cell Differentiation 
in Pup MCAs 
To obtain a more complete assessment of the effects of gestational Metyrapone 
and Ischemia on contractile function, contractile protein organization was examined via 
confocal microscopy of two different marker pairs: a) Non-Muscle Myosin Heavy Chain 
(NM-MHC, “SM-Embyronic”) and Smooth Muscle α-Actin (αActin) and b) Smooth 
Muscle Myosin Heavy Chain (SM-MHC) and αActin (Figure 4). For each protein pair 
examined, only pixels for which both proteins were above a set threshold intensity were 
examined, and the total number of pixels was defined as 100%. The pixels were then put 
into three different categories: 1) Low MHC / Low αA (Low/Low), where both MHC and 
αA were above our minimum threshold but below our set threshold, 2) Low MHC / High 
αA (Low/High), where MHC was above minimum threshold and αA was above the set 
maximum threshold, and 3) High MHC / High αA (High/High), where both MHC and αA 
were above set threshold. The effects of Ischemia and gestational Metyrapone on 
contractile protein organization were examined by looking at the distribution of pixels 
across each category.   
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Figure 4. Effects of Ischemia ± Metyrapone on Markers of Smooth Muscle Cell 
Differentiation. The effects of Ischemia with and without Metyrapone were examined in 
order to determine the colocalization of smooth muscle cell differentiation markers. 
Arteries were embedded in paraffin and cut into 5 µm thick sections. Colocalization was 
determined by confocal microscopy for two marker pairs: a) Non-Muscle Myosin Heavy 
Chain (NM-MHC) and Smooth Muscle a-Actin (αActin) and b) Smooth Muscle Myosin 
Heavy Chain (SM-MHC) and αActin. Shown above are representative sections from each 
of the four treatment groups (n = 6 animals). For all colocalization done, α-Actin was 
placed in the 488 nm (red) channel because it was the most abundant protein, while the 
least abundant protein was placed into the 633 nm (green) channel.  
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Effects of Ischemia ± Metyrapone on Colocalization of MHC Isoforms with Smooth 
Muscle α-Actin 
In sections stained for both SM-MHC and αActin (Figure 5, Upper Panels), there 
were no significant differences in any of the categories (Low/Low, Low/High, or 
High/High) when comparing Control Sham vs Ischemia arteries. By comparison in the 
Metyrapone-treated groups, there was a upward shift of pixels in response to Ischemia, 
with the Low/Low category showing an average increase of 6.7% by Ischemia and a 
subsequent decrease of 5.9% in the Low/High category. There were no changes in the 
High/High category. MET arteries showed a significant rightward shift compared with 
Sham arteries, with a significant decrease by 8.3% in the Low / Low category, as well as 
an increase in the Low/High and High/High categories by 6.3 and 2.0 %, respectively. As 
for arteries double stained with NM-MHC and αActin (Figure 5, Lower Panels), there 
were significant changes between Sham and Ischemia in Low/Low and High/High 
categories, with Ischemia arteries generally showing a leftward shift towards Low/Low 
categories: Ischemia arteries in the Low/Low category showed a significant increase by 
7.8% and a significant decrease of 4.0 % in the High/High category compared with Sham 
arteries. Metyrapone showed a different trend, with significant increases in the Low-Low 
category and decreases in the Low/High category; unlike with Control arteries, there 
were no significant differences between Sham+MET vs Ischemia+MET in the High/High 
category. With respect to MET-treatment alone, Sham vs Sham+MET arteries showed no 
differences except in the High/High category, with Sham+MET arteries showing a 
decrease of 2.7% compared with Sham. Compared with Ischemia arteries, 
Ischemia+MET arteries also showed a small, albeit significant increase in the High/High 
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category by 1.2%. Ischemia alone seems to support differentiation into a de-differentiated 
phenotype, while gestational treatment with Metyrapone seemed to reverse this effect, 
encouraging a more contractile phenotype.    
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Figure 5. Effects of Ischemia ± Metyrapone on Colocalization of MHC Isoforms with 
Smooth Muscle α-Actin. The figure above shows the pixel distributions for our four 
experimental groups with two different marker pairs: a) Smooth Muscle Myosin Heavy 
Chain (SM-MHC) and Smooth Muscle a-Actin (α-Actin) and b) Non-Muscle Myosin 
Heavy Chain (NM-MHC) with α-Actin. Within each marker pair, the total of all pixels 
across each of the three distributions (Low MHC/ Low αA, Low MHC/ High αA, High 
MHC, High αA) is 100%. Please note that the vertical scale for each of the three 
distributions are different (100% vs. 50% vs. 20%). Ischemia had no effect on pixel 
distributions with arteries stained for SM-MHC, but caused a leftward shift towards High 
MHC / High aA to Low MHC / Low αA in the NM-MHC category. Treatment with 
Metyrapone during gestation generally showed a reversed trend, with pixel distributions 
moving away from the Low MHC / High αA category during Ischemia toward Low MHC 
/ Low αA. In the NM-MHC category, there was also an increase in pixel distributions to 
High MHC/ High αA. Error bars indicate SEM with n=6 animals in all groups. Asterisks 
(*) indicate significant differences (P<0.05) between Sham and Ischemia groups, while 
daggers (†, ‡) indicate differences between Sham and Sham+Metyrapone, and Ischemia 
and Ischemia+Metyrapone groups, respectively.    
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Discussion 
The present study explores the hypothesis that glucocorticoid inhibition during 
gestation can influence cerebrovascular structure and function relations during postnatal 
life, and that this altered glucocorticoid profile can modify the vascular response to mild 
hypoxia-ischemia. Despite the use of a model of mild hypoxia-ischemia, there were key 
changes to vascular structure and function, indicating that vascular behavior may be 
different even in the absence of overt histological changes. Metyrapone, when 
administered during gestation, acted to counteract many of these effects. Together, these 
results suggest that a model of mild hypoxia-ischemia may be an additional method by 
which to study stroke in the neonate, and that glucocorticoid programming plays a key 
role in the ability of the cerebrovasculature to respond to a stressful stimulus.  
In this model of mild hypoxia-ischemia, corticosterone levels at 2 hours post-
surgery were significantly elevated compared with MET-treated post-surgery animals. 
Additionally, at the 24 hour post-hypoxia time period (48 hr post-surgery), there was a 
significant ~2-fold increase corticosterone in Ischemia arteries compared with Sham, 
Sham+MET, and Ischemia+MET groups (Figure 1). In the literature, there is 
considerable variability with respect to neonatal plasma corticosterone levels, with 
resting values ranging from as low as 1 ng/ml to about 60 ng/ml. In rodents, this might be 
partially explained by the hyporesponsive period (SHRP). As the name implies, this is a 
period during the early postnatal life of rodents in which time the HPA axis system is 
hyporesponsive to stressors. Basal corticosterone levels may become depressed and stay 
this way until around two weeks of age (32), though stressors can still elicit a response. 
Corticosterone levels that increased by about 2-fold are not unexpected and may indicate 
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that, while mild, hypoxia at 24-hours post-ischemia is a stress to the pups (22). Likewise, 
the finding that gestationally-treated MET animals also showed decreased corticosterone 
levels at the 2 and 48 hour time periods suggest that HPA axis reactivity was significantly 
altered by gestational inhibition of GCs. This is in agreement with results from other 
studies where acute administration of MET was found to decrease corticosterone levels in 
rat adults (21, 29) and pups (10, 28). In a pig model, it was found that administration of 
Metyrapone during gestation lowered plasma cortisol levels at postnatal day 14 (44). 
These findings are also in line with studies that looked at chronic glucocorticoid exposure 
during gestation, and found altered HPA axis reactivity into adulthood (7).  
Rat middle cerebral arteries taken for analysis by vessel-bath myography from the 
four different treatment groups revealed structural differences under pressure-passive 
conditions (Figure 2). Arteries from the Ischemia group were found to have increased 
passive diameters as well as decreased compliance and this phenotype was partially 
rescued by MET-treatment during gestation. The addition of gestational MET appears to 
have had an inhibitory effect on the normal ischemia-induced increase in stiffness. This 
could indicate that programming effects have occurred well before the hypoxic-ischemic 
insult could play a role. In the literature, this is a common finding with respect to excess 
antenatal glucocorticoid treatments, with evidence that high glucocorticoid exposure can 
induce vascular aging and stiffening effects (16, 27), perhaps through changes in vessel 
collagen, elastin, or extracellular matrix protein levels (13). The reverse experiment, 
however, with the inhibition of endogenous glucocorticoid has not been studied in any 
great detail, and the present study will be one of the first to publish such findings with 
respect to the neonatal cerebrovasculature. As for the mechanisms, it is likely that acute 
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stress caused by the hypoxic-ischemic insult contributed to the ischemia-induced increase 
in vascular stiffness. MET-treated animals, by contrast, may not have been exposed to the 
same rise in glucocorticoid levels, as shown by the time-course in Figure 1. This 
suggests that arterial stiffening may have been prevented due to MET-induced changes in 
HPA reactivity. 
In addition to measuring vessel behavior under passive pressure conditions, vessel 
myography is a technique that can also be used to investigate active contractility when 
the vessel is exposed to various external conditions (Figure 3). By the use of the 
intracellular fluorescent Ca++ dye fura-2, vessel contractility may also be recorded 
concurrently with measures of intracellular wall calcium. Together, these measurements 
provide insight into the functional behavior of our arteries.   Despite significant 
differences in total wall calcium levels in pressure-induced contractions when comparing 
Sham and Ischemia arteries, these results did not translate to any overall differences in 
contractility or calcium sensitivity.  
This is in line with other studies, where intracellular calcium levels post-hypoxia 
were found to be increased in neuronal somata and axons during the first 24-hours of 
recovery (19). As for why there were no net changes in contractility between Sham and 
Ischemia arteries, it is possible that the hypoxia-ischemia model used in this study may 
simply be too mild or that more statistical power (i.e. a larger cohort) is needed to detect 
a possible upward trend of pressure-induced diameter changes. It is also possible that 
other factors such as post-injury compensatory mechanisms may be at play or that the 
timing of the injury at 24-hours post-hypoxia may play a role. With respect to 
Metyrapone-treated Sham arteries compared with Sham arteries, there were significant 
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increases to vessel wall calcium without a significant loss or gain in contractility, 
indicating that calcium sensitivity may have been lost due to the programming effects of 
MET. This is in line with other work where it was found that corticosterone and 
dexamethasone both were shown to reduce intracellular calcium concentrations in 
astrocytes and neurons (43), suggesting that glucocorticoids may have an inhibitory effect 
on calcium sequestration or extrusion on cerebral smooth muscle cells as well. While the 
plasma corticosterone levels in Gestational MET-treated animals was not significantly 
less at the 24-hour post-hypoxia time point, the time-course presented in this study 
(Figure 1) indicates that the total exposure to circulating corticosterone levels post-injury 
was less than in control Ischemia animals. Hence, the normal inhibitory effect of 
corticosterone may have been temporarily lifted due to the programming-induced HPA 
axis changes, leading to an increase in intracellular levels of calcium in MET arteries.  
Whereas myogenic tone can be used as a measure of active vessel tone, it can also 
be helpful to look at maximum tone, such as from exposure to a high K+ solution. High 
levels of potassium act in a receptor-independent manner and stimulate vascular smooth 
muscle cells towards a maximally contractile state, also known as maximum tone. In the 
groups studied, the only significant differences were seen with respect to Ischemia and 
Ischemia+MET treatments, with Ischemia+MET arteries showing a significant 
depression in both potassium-induced contractility and calcium sensitivity vs in control 
Ischemia arteries. This occurred without any significant changes to wall calcium, which 
likely contributed to the significant loss of potassium-induced calcium sensitivity in 
Ischemia+MET arteries, at least compared with control Ischemia arteries. This indicates 
that the vessel responses to high potassium conditions has been fundamentally altered by 
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programming effects. Little work has been done with the effects of glucocorticoid 
inhibition on vessel contractility. One lab found that antenatal programming of 
glucocorticoids has previously been shown to alter coronary artery contractility to acetyl 
choline in lambs, and it did not affect KCl-induced contractions (41). However, our study 
did not document any significant differences in potassium-induced contractility with the 
deprivation of glucocorticoids during gestation which may be related to the difference in 
experimental design (inhibition vs administration of glucocorticoids). 
Changes in arterial structure and function co-occur with corresponding changes in 
vascular smooth muscle cell phenotype (Figures 4 & 5). Likewise, transitions of smooth 
muscle from one phenotype to another can in turn influence arterial structure and 
function as well as calcium handling (23, 35, 46). Such changes in differentiation patterns 
can be identified by looking at contractile protein expression (2, 11, 24). The two markers 
chosen for this study were Smooth Muscle Myosin Heavy Chain (SM-MHC, “SM2”) and 
Non-Muscle Myosin Heavy Chain (NM-MHC), both colozalized with and double-stained 
with α-actin. SM2 is a marker for fully differentiated contractile smooth muscle, while 
NM-MHC is considered a marker of developing or immature vascular smooth muscle. 
Together, they form a window into the vascular responses to hypoxic-injury and the 
programming induced by administration of Metyrapone during gestation. With respect to 
SM-MHC, we see no significant differences between Control Sham and Ischemia 
arteries, indicating that Ischemia alone does not seem to be contributing to differentiation 
of the smooth muscle into a more contractile phenotype. It is possible that changes may 
occur over time throughout the life of the animal; an aging study might be beneficial to 
look at the long-term effects of mild ischemia on cerebrovascular health. Nevertheless, 
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there is a significant effect of Metyrapone, which appears to be causing a shift to a more 
contractile phenotype, which then appears to be reversed when the arteries are taken from 
Ischemia+MET animals. From this data, we expected that Sham+MET arteries might 
show increased contractility vs Sham arteries. However, we did not see this behavior. 
Instead, what we see is that Sham+MET arteries appear to have increased pressure-
induced vessel wall calcium and decreased calcium sensitivity, while base contractility 
remained unchanged. Finally, Ischemia in combination with gestational glucocorticoid 
inhibition appears to have had a normalizing effect on smooth muscle cell differentiation, 
contributing to a new profile altogheter.  
With respect to NM-MHC (SM-Embryonic), we see a slightly different pattern. In 
this case, there is a leftward shift of pixels in response to Ischemia, perhaps indicating a 
shift to a less contractile, less differentiated phenotype. A similar pattern can be seen with 
arteries from gestational Metyrapone-treated pups. In response to Ischemia, there was a 
shift leftward and to the middle, suggesting a partially-differentiated or transition state, 
most likely in response to the hypoxic-ischemic injury. Again, Metyrapone 
administration appeared to have a normalizing, or perhaps stabilizing effect on the 
vascular response to Ischemic stress. From the perspective of the artery, MET treatment 
is protective against further damage via Ischemia, at least in the High NM-MHC/High 
NM-MHC category. Together, this data indicates that gestational Metyrapone, and 
likewise antenatal glucocorticoid status, may play a role in the development of normal 
artery physiology and the vascular response to injury. 
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Conclusions 
In conclusion, mild hypoxia-ischemia is a viable model by which to study 
vascular changes, and vice versa. The data presented in this paper provides support for 
the idea that vascular changes can occur even under very mild conditions, and that early 
life (mid-late gestational) glucocorticoid status can modify vascular responses even 
during postnatal life. There are several limitations to this study. Future work will be 
needed to determine precisely how programming by corticosterone is acting to alter 
structure-function relations in the cerebrovasculature and, subsequently, alter the pup’s 
response to hypoxia-ischemia. Special attention will need to be placed on exploring 
possible epigenetic mechanisms including miRNA activity. Likewise, the precise nature 
of the cerebrovascular changes merit further study, potentially with the help of organ 
culture work, investigating other markers of contractility, or perhaps delving deeper into 
calcium handling mechanisms like calcium sensitivity, influx, or release.  
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CHAPTER FOUR 
VALIDATION OF A MODEL OF MILD ISCHEMIA 
 
Introduction 
The following chapter describes experimental work that is still in progress, and 
does not constitute a completed project. Nevertheless, this section is a culmination of the 
efforts that have been put into validating our model of mild hypoxia-ischemia, as seen in 
Chapter Three. As indicated, we have developed a model of mild hypoxia-ischemia that 
results in global edema at 24 hours post-injury and is detectable by MRI but that does not 
result in a consolidated infarct or lesion, unlike more classic models which result in an 
average of 30-40% brain infarction. In the model, postnatal day 9 or 10 pups undergo 
unilateral carotid ligation and a 24-hour recovery period, followed by 90 minutes of 
exposure to 8% hypoxia. Due to the mildness of the injury, it was necessary to perform a 
number of validation experiments including histology, neurobehavioral studies, and MRI 
analysis. Collectively, these results indicate that we have developed a model of mild 
hypoxia-ischemia that does not result in a typical infarct pattern. Yet, despite this, we still 
see a number of significant vascular effects such as changes to vessel calcium sensitivity 
and structure. We conclude that the vasculature appears to be a very sensitive indicator of 
ischemic damage, warranting future analysis.  
 
Materials and Methods 
In order to provide a measurement of infarct levels, a separate set of experimental 
animals (n=5 per group; procedures as described in Chapter 3) were transcardially 
perfused with 4% paraformaldehyde using a positive pressure system. Brains were then 
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removed and stored in fixative overnight at 4  ̊C before being rinsed three times with PBS 
(pH 7.4) and then transferred to a 30% sucrose solution with PBS. Once saturated, the 
brains were then cut into 2 mm slices and frozen at -80  ̊C. Brain sections were later cut at 
25um using a fixed-blade cryostat (Leica CM3050S). Sections were then taken for 
histological analysis using the protocols described below.  
 
FluoroJade-C 
FluoroJade C was purchased from Histo-Chem (30mg 1FJC; Jefferson, Arkansas) 
and a stock solution of 0.01% was prepared ahead of time and stored at 4  C̊. A 
standardized procedure was then performed in which the brain sections were first 
rehydrated by use of a basic alcohol solution (1% NaOH in 80% EtOH), 70% EtOH, 
followed by distilled water. Slides were then immersed into a 0.06% potassium 
permanganate (KMnO4) solution for 5 minutes in order to reduce background signal, 
after which they were exposed to a diluted FJC solution (0.0001% FJC in 0.1% acetic 
acid) for 10 minutes on an autoshaker (0.60 min-1). The diluted FJC solution was used 
within one hour of preparation. Slides were then rinsed thrice in DI water, dried at room 
temperature, heated at 50 ̊C for 5 minutes, and then dipped in Histoclear. All slides were 
cover-slipped with Omnimount for imaging. All images were taken with a Keyence BZ-
X700 All in One Fluorescence Microscope. Tiled images were taken at 10X 
magnification and then combined with a 30% overlap using the BZ-X700 Analyzer 
software.  
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C-fos 
Anti-c-Fos (Ab-2) antibody was purchased from EMD Millipore (PC05-100UG; 
EMD Millipore, Temecula, CA).  Slides stored at -20 C̊ were warmed at 37 ̊C for 30 
minutes, washed thrice in PBS with 0.3% Triton X-100 (PBS-T, pH 7.45) for 10 min 
each. Endogenous peroxidases were quenched with 0.09% H2O2 in 1X PBS-T for 30 
minutes. Slides were washed again before undergoing blocking for 1 hour (2% normal 
goat serum and 1% bovine serum albumin in 1X PBS with 0.01% Triton X-100). The 
slides were then incubated with primary antibody at a titer of 1:20 (5 µg/ml) overnight at 
room temperature on a rotator. The next day, slides were washed again in PBS (thrice for 
15 minutes each), and then incubated in secondary antibody (1:300 Dylight 633 goat-anti 
rabbit) for 1.5 hours in the dark. The slides were then washed again in PBS-T twice for 
10 min followed by 10 min in 1X PBS before being dried. Vectashield Hard Set 
mounting media with DAPI was then applied and the slides were cover-slipped. 
 
Glial Fibrillary Acidic Protein (GFAP) 
Anti-Glial Fibrillary Acidic Protein (GFAP) Antibody was purchased from EMD 
Millipore (MAB3402; Temecula, CA). Slides were first warmed at room temperature and 
then 5 minutes at 37 C̊. Slides were washed in 1X PBS (pH 7.45) thrice for 15 minutes 
before being blocked (2% bovine serum albumin in PBS) for 1.5 hours. They were then 
incubated overnight on a rocker with primary antibody (1:1000 titer). The next day, slides 
were quickly washed in PBS followed by thrice in PBS for 15 minutes each. Slides were 
incubated for 1.5 hours in the dark (1:300 titer). They were then washed thrice for 10 
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minutes each before being dried and then set with Vectashield hard set mounting media 
and cover-slipped. All slides were stored at -4 C̊ until imaged. 
 
Ionized Calcium-Binding Adapter (IBA-1) Protein 
Anti ionized calcium-binding adapter molecule (IBA-1) rabbit antibody was 
purchased from Wako Pure Chemical Industries (019-19741; Richmond, VA). Slides 
were first warmed up at 37 C̊ for 5 minutes before being washed thrice in 1X PBS (pH 
7.45) for 15 minutes each. Slides were then exposed to 1% sodium dodecyl sulfate (SDS) 
for 10 minutes at room temperature. Excess SDS was removed and the slides were then 
washed thrice with PBS for 10 minutes each. Blocking was performed with 2% bovine 
serum albumin in 1X PBS at room temperature using a rocker. They were then incubated 
overnight in primary antibody (1:400 titer) on a rotator. The next day, slides were washed 
thrice in PBS with 0.1% Tween for 15 minutes each. Slides were then incubated in the 
dark with secondary antibody (1:150) for 2 hours. Slides were then washed twice with 
PBS-T followed by 10 minutes in 1X PBS. Slides were sealed with Vectashield Hard Set 
Mounting Media and then cover-slipped. As before, all slides were stored in the dark at 4 
C in refrigerator.  
 
Magnetic Resonance Imaging (MRI) 
Magnetic Resonance Imaging (MRI) scanning was performed by the laboratory of 
Dr. Andre Obenaus. Due to the ongoing nature of this project, the details of the methods 
used are not yet available.  
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Results & Discussion 
We have developed a model of mild hypoxia-ischemia, where surgery is 
performed on P9/P10 pups followed by a 24 hour recovery period with their dam and 
then 90 minutes of exposure to hypoxia (8% oxygen). This model of mild ischemia is 
characterized by changes to middle cerebral artery (MCA) structure and function, as 
measured by vessel bath myography and confocal microscopy, all of which occur without 
a consolidated infarct, as measured by FJ-C, IBA-1, c-fos, and cresyl violet staining. 
Characterization of the model of mild hypoxia-ischemia revealed evidence of increased 
ventricular edema, cellular stress/injury, and neurobehavioral differences. This model has 
provided us a unique opportunity to study vascular responses to injury in the absence of 
large infarcts, and supports the conclusion that the vasculature may be uniquely sensitive 
to ischemic injury and may serve as a first indicator, even before major neuronal 
involvement begins. 
In order to fully characterize our model of mild hypoxia-ischemia, we employed a 
number of methods including TTC, H&E, cresyl violet, FluoroJade-C, and MRI. The first 
method we used was TTC staining, which tests the metabolic activity of tissues by 
measuring dehydrogenase activity (3). Using this method, we demonstrated the often 
punctate and variable nature of the hypoxic-ischemic damage in the neonatal brain (See 
Figure 1). However, for a number of reasons, TTC did not seem to be an ideal method. 
Previous labs have documented that tissue can be metabolically stunned and later 
recover, leading to false negative results when staining with TTC (4). For these reasons, 
we decided to pursue alternative methods of injury quantification, including histology 
and MRI.    
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Figure 1. Measurements of Cerebral Infarct in a Model of Mild Ischemia. Initial attempts 
to quantify infarct volumes in this model of mild ischemia used TTC staining. Unilateral 
carotid ligation + 8% hypoxia resulted in cerebral ischemia. Representative frontal brain 
slices from four P12 Control-fed pups stained with 2% TTC showing infarcts after carotid 
ligation followed by either 90 minutes, A + B, or 120 minutes, C + D. Infarct percentages 
were analyzed in Photoshop and were comparable between treatment groups (27.6% vs 
27.9%). In particular, please note the punctate and diffuse quality of the ischemic insult. 
However, due to concerns about the reliability and accuracy of the TTC method, further 
experiments and validation were deemed necessary.  
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There are many histological techniques that are useful for determining brain 
injury: two of the most common ones are Cresyl Violet (CV), and hematoxylin and eosin 
(H&E). CV stains the Nissl substance in neurons and can be used in conjunction with 
light microscopy techniques to examine any gross histological changes that can occur 
following neuronal damage. Preliminary analysis using sections of our model did not 
reveal any obvious sections of damage (data not shown). H&E staining yielded similar 
results, and it was difficult to distinguish between healthy and injured tissue (data not 
shown). We did see evidence that our ischemic pups show signs of neurobehavioral 
differences (see Figure 2).  
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Figure 2. Behavior Data from Sham vs Ischemia Animals in mild Hypoxia-Ischemia: 
Righting Reflex, Geotaxis Reflex, and Open Field Exploration. Behavioral testing was 
performed on a number of pups from both Ischemia and Sham groups in order to determine 
neurological outcomes. It was found that the geotaxis reflex, but not the righting reflex or 
the open field test, were impaired post-injury. This result indicated that the model of mild 
hypoxia-ischemia, despite the lack of a consolidated infarct, still produces neurobehavioral 
differences. 
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From a functional whole-animal perspective, this would indicate that there is 
ischemic injury. However, it became clear that we needed more nuanced techniques 
would be required in order to validate our model. Next, we tried FluoroJade C (FJ-C) 
(See Figure 3). FJ-C is an acidic stain derived from fluorescein. The mechanism is 
currently unknown, but it is commonly used to stain degenerating neurons ex vivo and 
has been used in neonatal hypoxia-ischemia studies (1). We are still finishing our 
analysis, but thus far have not seen evidence of a consolidated infarct in our model of 
mild HIE.  
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Figure 3. 4-Way Histological Analysis with GFAP, IBA-1, c-fos, and FJC of Sham vs 
Ischemia Pup Brains. Preliminary analysis of serial cross sections of pup brains from Sham 
and Ischemia animals taken at P12, 24-hours post injury (n=1 for both Sham and Ischemia). 
4-Way histological staining with c-fos, GFAP, FJC, and IBA-1 was consistent with that of 
a mild hypoxia-ischemia injury and indicated the presence of widespread cellular stress 
and/or injury. A more complete quantitative analysis will be performed once the staining 
has been completed all treatment groups.  
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In addition to these vital dye staining techniques, there are also many potential 
biomarkers for neonatal brain damage including markers of immune system activity, cell 
death, or neuronal differentiation (19). We decided to investigate three of these: c-fos, 
GFAP, and IBA-1. First, c-fos is a proto-oncogene from the Fos family of transcription 
factors. It can be considered a marker of cellular stress akin to heat shock protein (HSP) 
70. It has been shown to be strongly activated following HIE, with c-fos potentially 
playing a neuroprotective role in certain regions such as the hippocampus (10, 19). Second, 
GFAP is an interfilament protein expressed by many cells of the central nervous system 
(CNS) including astrocytes and ependymal cells. Although it does not seem to be 
commonly stained for in the pup, it may sometimes be used as a biomarker of HIE (8) 
and is often used as a marker for neuronal damage in adult rats. We do not yet know what 
pattern of staining we will see with GFAP, though the cells may be swollen near the 
ventricles. A third possible marker is ionized calcium-binding adaptive molecule (IBA-
1), also known as allograft inflammatory factor 1 (AIF-1). It is a protein expressed in 
microglia and macrophages following a neuronal injury such as ischemia and can be 
found in activated macrophages (20). As there is frequently up-regulation of the immune 
system and specifically evidence of microglial upregulation during HIE (16), we should 
see some activity after IBA-1 staining. For all of these methods, we are still waiting on 
our completed results (See Figure 3).  
Another method that we have made use of is magnetic resonance imaging (MRI). 
MRI is a well-established and sensitive method for characterizing early types of stroke 
and is a key diagnostic tool in the clinic (9).  Because we have suspected that our model 
was mild, we have turned to increasingly more sensitive methods of injury quantification. 
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While we are still waiting on a complete analysis of our MRI results, preliminary 
evidence from Sham and Ischemic animals suggests that our injury is primarily a global 
one, affecting both the contralateral and ipsilateral sides, and resulting in edema and 
ventricular swelling (see Figure 4). Several studies have looked at models of milder HIE 
(17, 22, 28, 29). In general, there is relative agreement that the intensity of the insult can be 
modified by factors such as the duration of the hypoxic insult. Ninety minutes is usually 
considered to be the threshold to produce a lesion. In these models of mild ischemia, 
some of the most common features are oligodendrocyte injury, resulting in 
demylelination, predominantly white matter injury, and altered diffusion tensor MR 
imaging. In our case, we had originally hypothesized that exposing the pups to hypoxia at 
the 24 hour mark would increase infarct levels due to the neuroprotective effects of 
isoflurane. Instead, we now conclude that the long recovery period post-surgery was an 
important factor in determining the severity of the insult, and that our model most closely 
resembles that produced by a shorter dosage of hypoxia. Although we did not perform 
myelin basic protein (MBP) immunostaining, we would expect a similar pattern as to 
what has been previously reported (see references above).   
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Figure 4. Comparison of T2 and ADC in Sham vs Ischemia. MRI scanning (T2 and ADC) 
was performed on Sham and Ischemia ex vivo pup brains in order to characterize the injury 
(n=5 per group).  It was found that mild Ischemia compared with Sham significantly 
increased MRI T2, and an analysis of the slope between T2 and ADC were found to be 
significantly different. This finding is consistent with cellular swelling and edema.  
  
108 
Clinically, perinatal stroke frequently results in injury to the brain stem, thalamus, 
putamen, peri-Rolandic cerebral cortex resulting in motor impairments characteristic with 
cerebral palsy (13).  Full term infants are more sensitive to grey matter injury while 
premature infants may be more sensitive to white matter injury. Motor function 
impairment seems to be a common symptom with about ½ to ⅔ of infants displaying 
such behavior. Grey matter injury may be more common in full term infants, whereas 
diffuse injury is more applicable to premature newborns (9). Much of what we know 
about neonatal ischemic was adapted from research in adults. However, neonatal stroke is 
not the same as adult stroke, showing a number of differences.  There are specific 
vulnerabilities of the neonatal brain which should be taken into account, including 
increased susceptibility to excitotoxicity, free radical injury, oxidative stress. The 
neonatal brain also shows a greater tendency toward apoptotic cell death, as well as 
sensitivity to oligodendrocyte injury (12).  With respect to the vasculature, blood brain 
barrier (BBB) function and neuronal proteases may also be compromised during HIE (2). 
Angiogenesis after stroke is also thought to be important. Finally, endothelial progenitor 
cells (EPC’s) may play an important role in HIE. 
Studying the effects of GC on development in humans is complicated and likely 
involves both genomic and non-genomic actions. GCs may increase neuronal stem 
progenitor cells (NSPC) proliferation. NSPCs play a key role in development and have 
many nuclear receptors, including GR (5). GR expression increases and peaks at around 
P15 (14). A number of studies have looked specifically at the effects of glucocorticoids 
on neonatal stroke. In a 1995 study, treatment of synthetic glucocorticoid dexamethasone 
4 hours prior to infarct resulted in neuroprotection in an HIE model (25, 26). Two stroke 
109 
studies reported neuroprotection with administration of MET 30 minutes (24)  and 1 hour 
post-hypoxia (6). Infarcts were worsened when MET was administered post-insult (23). A 
notable difference between these studies and the present one is that it involves acute 
administration immediately before or after stroke. Given this evidence, it seems likely 
that HPA axis activity has an influence on stroke outcome (30). 
With respect to antenatal glucocorticoids, some studies have been performed, 
most often in order to investigate the ramifications of glucocorticoid administered before 
birth in order to prepare the premature fetus’s lungs for birth. GCs confer significant 
benefits to infant survival and lung maturation (5), despite the potential for long-term 
health problems.  With respect to MET treatment before birth, there are not many studies 
that have looked at this combination and the precise effects of glucocorticoid inhibition 
during gestation are unknown.  Our work has indicated a mild effect of gestational 
metyrapone on weight gain, with and without ischemia (see Figure 5). The effects of 
MET on the brain are not very well characterized, but may include altered dopaminergic 
and serotoninergic pathways. Leret et al found that Metyrapone administered from E0 to 
E17 of gestation resulted in alterations to dopamine and serotonin signaling that persisted 
to at least P90 (15). While the timing and method of dosage was different (E10-E21, 0.5 
mg/ml via drinking water vs E0-E17, 45 mg/kg via i.p. injection), these results 
nevertheless indicate that glucocorticoid inhibition, like glucocorticoid excess, may also 
result in fetal programming. This is in agreement with our findings from Chapter 3.  
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Figure 5. Body Weights of Pups at P11/12 Post-Treatment. Body weights of rat pups from 
all four treatment groups were measured immediately prior to sacrifice on postnatal days 
11 and 12. Compared with Sham animals, the Ischemia group showed a significant 
decrease in body weight. By comparison, MET-treated pups did not show any significant 
weight loss post-Ischemia. MET-treated animals also exhibited a slight but significant 
weight increase compared with both Sham and Ischemia pups. This data indicates that 
gestational Metyrapone is protective against Ischemia-induced weight loss and may 
contribute to increased body weight at postnatal days 11 and 12.  
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The specific effects of GC influences on the developing vasculature are 
understudied. Some papers, in their quest to understand the dramatic effects of GCs on 
lung maturation (especially with regards to surfactant production) have looked at the 
effects that GCs may have in the vasculature of the lungs (7, 11). Nevertheless, little is 
known about the vasculature in other organ systems such as the brain. One study from 
2008 found that fetal cerebral blood flow in lambs was decreased 4 hours after two 
intramuscular betamethasone injections, indicating a vasoconstrictor effect by GCs (18).  
Another study using a similar model also reported decreased middle cerebral artery 
vascular contractility in adult sheep that were exposed to two doses of prenatal 
betamethasone(18). These two studies combined suggest that GC exposure early in life 
may affect adults differently than fetuses, with a tendency toward increased contractility 
as a fetus vs decreased contractility as an adult. A third paper also suggested that GCs 
may have effects on the cerebral vasculature. In a model of periventricular-
intraventricular hemorrhage, prenatal glucocorticoid administration was shown to 
significantly reduce the risk of hemorrhage and mortality rate in preterm infants (21). 
Work by Vinukonda et al in a germinal matrix hemorrhage model has shown that prenatal 
GC exposure may reduce angiogenesis via VEGF, increase TGF-ß levels, and suppress 
endothelial proliferation (27). The authors concluded that reduced vascular density may 
be a factor in the reduced risk following GC therapy. Although this work has been done 
with respect to a model of cerebral hemorrhage, it nevertheless gives us some insight into 
the status of the vasculature following GC exposure and the possibility that GCs may 
have a stabilizing effect on the developing vasculature. Though it requires some 
speculation, the inhibition of glucocorticoids during pregnancy via metyrapone would 
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then be expected to act in an opposite way, perhaps favoring a more angiogenic 
phenotype and allowing for more collateral circulation depending on the brain region.  
 
Conclusions 
In conclusion, we have presented preliminary evidence that our model of mild 
hypoxia-ischemia may be a novel technique for examining vascular injury in the absence 
of a consolidated ischemic infarct. To support this claim, we have presented evidence 
from neurobehavioral studies, multiple histological stains, and MRI data. It should be 
noted, however, that this work does not yet include our Metyrapone groups, either 
Ischemia+MET or Sham+MET, and that these experiments are currently underway. 
Likewise, in the context of the greater dissertation and project, it will also be necessary to 
validate the model with respect to maternal food restriction.  
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CHAPTER FIVE 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Maternal food restriction and other related pathologies such as intrauterine growth 
restriction can contribute to lifelong chronic health problems in adults. These conditions 
are all connected by adverse conditions during critical periods of development where key 
structural and functional decisions are made by the growing fetus in response to changing 
environmental conditions. These development differences then manifest as permanent 
physiological and anatomical changes which the fetus retains as they mature to 
adulthood. Of the systems effected by food restriction, this dissertation has primarily 
focused on changes related to the cerebrovasculature.  
Chapter One introduced the general research topic and sought to provide some 
important background information about the state of the food restriction field. It 
introduced the concept of fetal programming, and how glucocorticoids may be at least 
partially responsible for food restriction-related anatomical changes. In it, we also 
explored the basics of cerebrovascular autoregulation, vascular anatomy, and smooth 
muscle physiology. We also spoke about the clinical impact that hypoxia-ischemia may 
have on an infant and some of the treatments currently available, as well as the gap in 
knowledge that this dissertation seeks to address.  
In Chapter Two, we established that 50% maternal food restriction during Days 
10 through 21 of gestation can produce significant changes to the cerebrovascular 
structure and function in 8-month old adult male offspring and that these vascular 
changes were detectable by our chosen methods of vessel bath myography and 
immunohistochemistry in combination with confocal microscopy. This paper emphasized 
117 
the importance of glucocorticoid-related mechanisms by showing that gestationally 
administered Metyrapone, a glucocorticoid synthesis inhibitor, reversed some of the 
effects of MFR, most notably vascular stiffness. These experiments set the stage to ask 
questions about the cerebrovasculature at earlier time points, especially the neonatal 
period. Mainly, how early do vascular related changes such altered passive compliance or 
depressed contractility begin? Are these differences detectable during postnatal life?  On 
a more practical level, we also wanted to know what the programming effects of 
Metyrapone alone would be, as well as to find out how much of the changes that we saw 
at 8-months of age were due to the animal’s overall adiposity and metabolic changes, 
which can also influence vascular health, and how much was due strictly to food-
restriction. To do so, it was necessary to examine a neonatal model, before these overt 
signs of premature aging. 
In Chapter Three, we began asking questions about the neonatal vasculature. In 
order to begin a thorough analysis of food restricted arteries, however, it was first 
necessary to establish a baseline of pup artery structure and function.  To do so, we 
developed a model of mild ischemia, the purpose of which was to provide an appropriate 
vascular stressor by which to test the normal pup physiological response. Control Sham 
and Ischemia pups were exposed to hypoxia 24-hours post-surgery.  Likewise, given the 
importance of excess glucocorticoid exposure during pregnancy, it was also necessary to 
determine the effects of glucocorticoid inhibition during pregnancy as a control 
experiment. Hence, a second cohort of animals was also studied alongside the first Sham 
and Ischemia groups. Female pregnant rats were administered Metyrapone on Day 11 
through 21 of gestation, after which time they were administered normal drinking water. 
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By adapting the methods of vessel-bath myography and immunohistochemistry combined 
with confocal microscopy to our pup arteries, we found that our model of mild ischemia 
appears to be a sufficient stressor to produce vascular structure and function changes, and 
that gestational Metyrapone again appears to mediate and oppose some of these ischemia-
induced changes. This indicates that glucocorticoid status established well in advance of 
an ischemic insult during mid-late gestation can fundamentally alter the vascular 
response to ischemia during the neonatal period.  
Chapter Four includes ongoing experimental work for establishing and validating 
our model of mild ischemia. Some of the methods used to quantify and assess the brain 
injury of our pups include MRI scanning techniques, histological stains, and 
neurobehavioral analysis. From our preliminary data, we believe that we have developed 
a model of mild ischemia that produces inflammation and cellular swelling without a 
consolidated infarct. Despite this mild infarct, we nonetheless established in Chapter 
Three that even mild hypoxia-ischemia is capable of eliciting a vascular response, which 
may be a key finding for future work. A complete analysis with our Metyrapone 
treatment group is currently underway and should provide additional information about 
the nature of our model. 
Future work will involve looking into the effects of programming via gestational 
metyrapone and maternal food restricted animals in addition to our current neonatal 
stroke model. Our lab would also like to build upon work started with our collaborators at 
Harbor UCLA and explore the possibility of additional epigenetic mechanisms such the 
influence of miRNAs, especially miRNA 29C.  In keeping with this theme, it would also 
be of interest to explore other ways by which food restriction may be acting, by delving 
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into DNA methylation studies or perhaps histone acetylation. Such work has been 
explored in other tissues and models, but a focus on the cerebrovasculature could yield 
some unique insights. Together, this body of work should advance our understanding of 
how prenatal programming acts to mediate future health outcomes as well as inform 
clinicians on how to best treat high risk pregnancies.  
 
 
